Gene Symbol | Gene ID | Gene Info |
---|---|---|
Spib
|
ENSMUSG00000008193.7 | Spi-B transcription factor (Spi-1/PU.1 related) |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_44527848_44528304 | Spib | 3200 | 0.080138 | 0.26 | 5.8e-02 | Click! |
chr7_44531382_44531533 | Spib | 181 | 0.830223 | 0.25 | 6.5e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_148379511_148379873 | 24.42 |
Slc7a1 |
solute carrier family 7 (cationic amino acid transporter, y+ system), member 1 |
8146 |
0.24 |
chr18_56870974_56871252 | 20.68 |
Gm18087 |
predicted gene, 18087 |
44975 |
0.14 |
chr6_38900298_38900449 | 19.14 |
Tbxas1 |
thromboxane A synthase 1, platelet |
18607 |
0.18 |
chr13_19127362_19127551 | 18.58 |
Amph |
amphiphysin |
7667 |
0.21 |
chr5_118483972_118484153 | 16.72 |
Gm15754 |
predicted gene 15754 |
2905 |
0.27 |
chr2_174614009_174614190 | 16.14 |
Vmn1r-ps1 |
vomeronasal 1 receptor, pseudogene 1 |
22869 |
0.17 |
chr3_100436826_100437140 | 15.46 |
Gm43121 |
predicted gene 43121 |
851 |
0.54 |
chr5_140596922_140597129 | 15.05 |
Gm43703 |
predicted gene 43703 |
9526 |
0.12 |
chr17_84181102_84182153 | 14.23 |
Gm36279 |
predicted gene, 36279 |
4129 |
0.18 |
chr2_32081416_32081630 | 14.06 |
Fam78a |
family with sequence similarity 78, member A |
2171 |
0.19 |
chr18_65802362_65802604 | 13.96 |
Sec11c |
SEC11 homolog C, signal peptidase complex subunit |
1181 |
0.36 |
chr1_87960195_87960349 | 13.89 |
Usp40 |
ubiquitin specific peptidase 40 |
6923 |
0.12 |
chr13_74735599_74735790 | 13.86 |
Cast |
calpastatin |
1352 |
0.45 |
chr19_10013816_10014234 | 13.81 |
Rab3il1 |
RAB3A interacting protein (rabin3)-like 1 |
991 |
0.4 |
chr11_89017858_89018018 | 13.64 |
Trim25 |
tripartite motif-containing 25 |
18562 |
0.1 |
chr7_115941774_115942065 | 13.57 |
Sox6 |
SRY (sex determining region Y)-box 6 |
53167 |
0.12 |
chr4_132078479_132078695 | 13.51 |
Epb41 |
erythrocyte membrane protein band 4.1 |
3266 |
0.14 |
chr4_116720426_116721428 | 13.45 |
Tesk2 |
testis-specific kinase 2 |
21 |
0.96 |
chr6_58641996_58642178 | 13.32 |
Abcg2 |
ATP binding cassette subfamily G member 2 (Junior blood group) |
1505 |
0.46 |
chr7_132765912_132766076 | 13.26 |
Fam53b |
family with sequence similarity 53, member B |
10922 |
0.2 |
chr5_91961007_91961165 | 13.07 |
Thap6 |
THAP domain containing 6 |
1303 |
0.26 |
chr2_140163585_140163736 | 12.97 |
Esf1 |
ESF1 nucleolar pre-rRNA processing protein homolog |
3177 |
0.21 |
chr11_117114399_117114849 | 12.83 |
Sec14l1 |
SEC14-like lipid binding 1 |
544 |
0.64 |
chr4_132247566_132247721 | 12.75 |
Gmeb1 |
glucocorticoid modulatory element binding protein 1 |
1575 |
0.16 |
chr12_103343573_103343732 | 12.66 |
Asb2 |
ankyrin repeat and SOCS box-containing 2 |
5279 |
0.12 |
chr13_8999532_8999796 | 12.62 |
Gtpbp4 |
GTP binding protein 4 |
3581 |
0.13 |
chr18_25097355_25097753 | 12.59 |
Fhod3 |
formin homology 2 domain containing 3 |
26807 |
0.22 |
chr15_103453637_103453855 | 12.23 |
Nckap1l |
NCK associated protein 1 like |
48 |
0.96 |
chr5_148897060_148897772 | 12.20 |
Katnal1 |
katanin p60 subunit A-like 1 |
18337 |
0.11 |
chr11_57956307_57956458 | 12.10 |
Gm12245 |
predicted gene 12245 |
7297 |
0.16 |
chr10_20905453_20905622 | 11.92 |
Rps2-ps3 |
ribosomal protein S2, pseudogene 3 |
26564 |
0.19 |
chr1_174172419_174172571 | 11.86 |
Spta1 |
spectrin alpha, erythrocytic 1 |
281 |
0.82 |
chr4_140701770_140702866 | 11.83 |
Rcc2 |
regulator of chromosome condensation 2 |
845 |
0.47 |
chr11_34783822_34783973 | 11.79 |
Dock2 |
dedicator of cyto-kinesis 2 |
5 |
0.98 |
chr10_42270768_42271069 | 11.73 |
Foxo3 |
forkhead box O3 |
5778 |
0.27 |
chr3_148220928_148221079 | 11.73 |
Gm43574 |
predicted gene 43574 |
90759 |
0.09 |
chr11_11730242_11730393 | 11.37 |
Gm12000 |
predicted gene 12000 |
33878 |
0.14 |
chr4_121014564_121014855 | 11.35 |
Smap2 |
small ArfGAP 2 |
2538 |
0.19 |
chr12_12301967_12302128 | 11.30 |
Fam49a |
family with sequence similarity 49, member A |
39858 |
0.19 |
chr10_68431410_68431585 | 11.27 |
Cabcoco1 |
ciliary associated calcium binding coiled-coil 1 |
94270 |
0.07 |
chr16_92715891_92716069 | 11.12 |
Runx1 |
runt related transcription factor 1 |
18652 |
0.24 |
chr9_45274229_45274429 | 11.01 |
Il10ra |
interleukin 10 receptor, alpha |
5180 |
0.12 |
chr6_122921535_122921686 | 10.72 |
Clec4a1 |
C-type lectin domain family 4, member a1 |
238 |
0.89 |
chr3_60473003_60473181 | 10.68 |
Mbnl1 |
muscleblind like splicing factor 1 |
13 |
0.99 |
chr7_103762479_103762630 | 10.56 |
Olfr630 |
olfactory receptor 630 |
5221 |
0.08 |
chr18_57085163_57085344 | 10.40 |
Gm18739 |
predicted gene, 18739 |
32027 |
0.15 |
chr11_11684707_11686418 | 10.38 |
Gm11999 |
predicted gene 11999 |
162 |
0.73 |
chr9_47734060_47734211 | 10.38 |
Gm47198 |
predicted gene, 47198 |
37006 |
0.18 |
chr1_58953782_58953940 | 10.26 |
Trak2 |
trafficking protein, kinesin binding 2 |
7524 |
0.16 |
chr9_58246140_58246457 | 10.19 |
Pml |
promyelocytic leukemia |
3325 |
0.15 |
chr1_179551451_179551615 | 10.17 |
Cnst |
consortin, connexin sorting protein |
5024 |
0.16 |
chr9_70503020_70503614 | 10.04 |
Rnf111 |
ring finger 111 |
37 |
0.96 |
chr17_26514334_26514507 | 10.03 |
Dusp1 |
dual specificity phosphatase 1 |
5901 |
0.11 |
chr7_45238735_45238977 | 9.90 |
Cd37 |
CD37 antigen |
16 |
0.92 |
chr2_73054152_73054303 | 9.89 |
Gm13665 |
predicted gene 13665 |
62521 |
0.08 |
chr7_127807507_127807676 | 9.89 |
Stx1b |
syntaxin 1B |
3333 |
0.09 |
chr19_37238745_37238896 | 9.87 |
Gm25268 |
predicted gene, 25268 |
5336 |
0.15 |
chr6_90712861_90713488 | 9.84 |
Iqsec1 |
IQ motif and Sec7 domain 1 |
3355 |
0.21 |
chr2_27232376_27232738 | 9.84 |
Sardh |
sarcosine dehydrogenase |
140 |
0.95 |
chr7_111004187_111004476 | 9.80 |
Mrvi1 |
MRV integration site 1 |
21870 |
0.15 |
chr12_116141885_116142036 | 9.78 |
Gm20658 |
predicted gene 20658 |
3312 |
0.14 |
chr10_62543549_62543764 | 9.76 |
Srgn |
serglycin |
16205 |
0.12 |
chr9_72409226_72409810 | 9.66 |
Gm27255 |
predicted gene 27255 |
250 |
0.55 |
chr4_156255141_156255347 | 9.66 |
Samd11 |
sterile alpha motif domain containing 11 |
28 |
0.92 |
chr6_120956690_120957084 | 9.63 |
Mical3 |
microtubule associated monooxygenase, calponin and LIM domain containing 3 |
836 |
0.46 |
chr13_45109113_45109264 | 9.61 |
Gm40932 |
predicted gene, 40932 |
2295 |
0.28 |
chrX_102036928_102037079 | 9.57 |
Nhsl2 |
NHS-like 2 |
13848 |
0.14 |
chr11_96925843_96926029 | 9.56 |
Prr15l |
proline rich 15-like |
2168 |
0.15 |
chr5_37457926_37458192 | 9.53 |
Evc2 |
EvC ciliary complex subunit 2 |
42200 |
0.16 |
chr10_40477032_40477196 | 9.40 |
Gm18671 |
predicted gene, 18671 |
71778 |
0.08 |
chr1_193665119_193665299 | 9.40 |
Mir205hg |
Mir205 host gene |
155035 |
0.04 |
chr18_68195855_68196033 | 9.34 |
Gm18149 |
predicted gene, 18149 |
26977 |
0.16 |
chr9_110459312_110459495 | 9.33 |
Klhl18 |
kelch-like 18 |
3077 |
0.18 |
chr14_99263886_99264234 | 9.30 |
Gm4412 |
predicted gene 4412 |
27576 |
0.15 |
chr7_3898175_3898326 | 9.18 |
Gm14548 |
predicted gene 14548 |
130 |
0.93 |
chr17_26535257_26535653 | 9.12 |
Gm50275 |
predicted gene, 50275 |
2772 |
0.15 |
chr7_123459839_123460148 | 9.05 |
Aqp8 |
aquaporin 8 |
2298 |
0.3 |
chr13_47108976_47109134 | 9.03 |
1700026N04Rik |
RIKEN cDNA 1700026N04 gene |
2636 |
0.17 |
chr6_149193406_149193557 | 9.01 |
Amn1 |
antagonist of mitotic exit network 1 |
4769 |
0.17 |
chr6_94813538_94813691 | 8.99 |
Gm7833 |
predicted gene 7833 |
6916 |
0.15 |
chr5_136149279_136149602 | 8.96 |
Alkbh4 |
alkB homolog 4, lysine demethylase |
10659 |
0.09 |
chr11_34031357_34031508 | 8.93 |
Lcp2 |
lymphocyte cytosolic protein 2 |
15488 |
0.19 |
chr3_27689536_27689707 | 8.91 |
Fndc3b |
fibronectin type III domain containing 3B |
20777 |
0.25 |
chr11_11689072_11689235 | 8.87 |
Ikzf1 |
IKAROS family zinc finger 1 |
2708 |
0.22 |
chr17_26957161_26957343 | 8.86 |
Syngap1 |
synaptic Ras GTPase activating protein 1 homolog (rat) |
574 |
0.5 |
chr18_15201576_15201727 | 8.82 |
Gm50035 |
predicted gene, 50035 |
6140 |
0.21 |
chr9_31271786_31271953 | 8.78 |
Gm7244 |
predicted gene 7244 |
2952 |
0.22 |
chr7_103763148_103763347 | 8.78 |
Olfr630 |
olfactory receptor 630 |
5914 |
0.07 |
chr6_88915651_88916398 | 8.77 |
Gm44178 |
predicted gene, 44178 |
3684 |
0.14 |
chr12_117479152_117479303 | 8.76 |
Rapgef5 |
Rap guanine nucleotide exchange factor (GEF) 5 |
37252 |
0.2 |
chr6_123289063_123289230 | 8.75 |
Clec4e |
C-type lectin domain family 4, member e |
720 |
0.6 |
chr14_31423233_31423413 | 8.68 |
Sh3bp5 |
SH3-domain binding protein 5 (BTK-associated) |
5646 |
0.16 |
chr3_37659633_37660007 | 8.60 |
Gm43820 |
predicted gene 43820 |
15213 |
0.11 |
chr15_39957733_39957899 | 8.57 |
AU022793 |
expressed sequence AU022793 |
4833 |
0.19 |
chr14_98749454_98749605 | 8.55 |
Gm27034 |
predicted gene, 27034 |
34716 |
0.21 |
chr11_115717711_115718019 | 8.54 |
Gm11703 |
predicted gene 11703 |
6943 |
0.1 |
chr3_37332194_37332387 | 8.49 |
Gm12540 |
predicted gene 12540 |
5218 |
0.1 |
chr11_87756393_87756787 | 8.46 |
Mir142 |
microRNA 142 |
274 |
0.51 |
chr12_108631259_108631410 | 8.45 |
Evl |
Ena-vasodilator stimulated phosphoprotein |
4376 |
0.18 |
chr7_103861338_103861749 | 8.37 |
Hbb-y |
hemoglobin Y, beta-like embryonic chain |
8327 |
0.06 |
chr6_122571092_122571243 | 8.37 |
Gm16556 |
predicted gene 16556 |
318 |
0.79 |
chr6_31613580_31613892 | 8.30 |
Gm43154 |
predicted gene 43154 |
8447 |
0.19 |
chr7_135598515_135598830 | 8.29 |
Ptpre |
protein tyrosine phosphatase, receptor type, E |
5284 |
0.2 |
chr6_48700494_48700721 | 8.27 |
Gimap6 |
GTPase, IMAP family member 6 |
5629 |
0.08 |
chr5_20930526_20930677 | 8.16 |
Rsbn1l |
round spermatid basic protein 1-like |
8202 |
0.17 |
chr11_109559252_109559566 | 8.14 |
Arsg |
arylsulfatase G |
15655 |
0.15 |
chr15_72928715_72929023 | 8.13 |
Gm3150 |
predicted gene 3150 |
15512 |
0.25 |
chr7_101324449_101324600 | 8.12 |
Gm20476 |
predicted gene 20476 |
1707 |
0.2 |
chr13_94159218_94159369 | 8.09 |
Lhfpl2 |
lipoma HMGIC fusion partner-like 2 |
13517 |
0.18 |
chr6_129407416_129407567 | 8.07 |
Clec9a |
C-type lectin domain family 9, member a |
1371 |
0.26 |
chr7_16239699_16240021 | 8.05 |
C5ar2 |
complement component 5a receptor 2 |
2471 |
0.15 |
chr4_32304202_32304739 | 8.05 |
Bach2it1 |
BTB and CNC homology 2, intronic transcript 1 |
52709 |
0.13 |
chr11_79071590_79071929 | 8.04 |
Ksr1 |
kinase suppressor of ras 1 |
2727 |
0.3 |
chr11_50354825_50355149 | 8.03 |
Cby3 |
chibby family member 3 |
525 |
0.66 |
chr2_14631723_14631874 | 7.99 |
Gm13268 |
predicted gene 13268 |
4477 |
0.13 |
chr5_148886186_148886484 | 7.99 |
Katnal1 |
katanin p60 subunit A-like 1 |
7256 |
0.14 |
chr6_134262937_134263259 | 7.98 |
Etv6 |
ets variant 6 |
15533 |
0.16 |
chr1_97659502_97659711 | 7.94 |
AC099860.1 |
proline rich protein BstNI subfamily 4 (PRB4), pseudogene |
1225 |
0.43 |
chr1_190038218_190038369 | 7.89 |
Smyd2 |
SET and MYND domain containing 2 |
115930 |
0.05 |
chr4_95385679_95385958 | 7.86 |
Gm29064 |
predicted gene 29064 |
16972 |
0.23 |
chr16_22900562_22900713 | 7.86 |
Ahsg |
alpha-2-HS-glycoprotein |
5773 |
0.12 |
chr6_120795527_120795678 | 7.82 |
Gm25193 |
predicted gene, 25193 |
2068 |
0.24 |
chr11_94386265_94386700 | 7.77 |
Abcc3 |
ATP-binding cassette, sub-family C (CFTR/MRP), member 3 |
6438 |
0.17 |
chrX_164425306_164425513 | 7.63 |
Piga |
phosphatidylinositol glycan anchor biosynthesis, class A |
101 |
0.96 |
chr4_40847147_40847736 | 7.61 |
Mir5123 |
microRNA 5123 |
2697 |
0.15 |
chr7_30412725_30412876 | 7.60 |
Tyrobp |
TYRO protein tyrosine kinase binding protein |
960 |
0.28 |
chr11_87751706_87751911 | 7.58 |
Mir142hg |
Mir142 host gene (non-protein coding) |
3769 |
0.1 |
chr5_147888930_147889082 | 7.54 |
Slc46a3 |
solute carrier family 46, member 3 |
5809 |
0.17 |
chr1_132341845_132342014 | 7.53 |
F730311O21Rik |
RIKEN cDNA F730311O21 gene |
94 |
0.95 |
chr2_36216526_36217506 | 7.48 |
Gm13431 |
predicted gene 13431 |
191 |
0.91 |
chr15_9714811_9714962 | 7.47 |
Spef2 |
sperm flagellar 2 |
33891 |
0.23 |
chr11_84824090_84824244 | 7.42 |
Mrm1 |
mitochondrial rRNA methyltransferase 1 |
4652 |
0.13 |
chr7_104369887_104370038 | 7.37 |
Trim30b |
tripartite motif-containing 30B |
78 |
0.93 |
chr7_119251106_119251439 | 7.35 |
Gm4083 |
predicted gene 4083 |
50435 |
0.12 |
chr4_85953643_85953827 | 7.34 |
Gm25811 |
predicted gene, 25811 |
89759 |
0.09 |
chr15_96344702_96344855 | 7.30 |
Arid2 |
AT rich interactive domain 2 (ARID, RFX-like) |
12062 |
0.21 |
chr17_34603586_34604054 | 7.29 |
Rnf5 |
ring finger protein 5 |
130 |
0.74 |
chr3_84456098_84456534 | 7.24 |
Fhdc1 |
FH2 domain containing 1 |
2553 |
0.34 |
chr7_100855916_100856116 | 7.24 |
Relt |
RELT tumor necrosis factor receptor |
286 |
0.87 |
chr19_17359568_17359719 | 7.24 |
Gcnt1 |
glucosaminyl (N-acetyl) transferase 1, core 2 |
2976 |
0.3 |
chr9_70703949_70704124 | 7.14 |
Adam10 |
a disintegrin and metallopeptidase domain 10 |
25020 |
0.16 |
chr9_106230120_106230271 | 7.12 |
Alas1 |
aminolevulinic acid synthase 1 |
6889 |
0.1 |
chr10_105500545_105500743 | 7.12 |
Gm15666 |
predicted gene 15666 |
6456 |
0.15 |
chr10_62506208_62506533 | 7.11 |
Srgn |
serglycin |
1385 |
0.34 |
chr9_121426081_121426568 | 7.10 |
Trak1 |
trafficking protein, kinesin binding 1 |
10349 |
0.19 |
chr15_9463851_9464040 | 7.05 |
Gm50456 |
predicted gene, 50456 |
11557 |
0.2 |
chr4_115857422_115857573 | 7.02 |
Mknk1 |
MAP kinase-interacting serine/threonine kinase 1 |
391 |
0.78 |
chr8_123859017_123859410 | 7.02 |
Ccsap |
centriole, cilia and spindle associated protein |
317 |
0.78 |
chr15_97361098_97361258 | 7.00 |
Pced1b |
PC-esterase domain containing 1B |
24 |
0.98 |
chr6_137696910_137697122 | 6.98 |
Strap |
serine/threonine kinase receptor associated protein |
38062 |
0.16 |
chr8_72008465_72008616 | 6.93 |
Cyp4f18 |
cytochrome P450, family 4, subfamily f, polypeptide 18 |
1086 |
0.3 |
chr9_120116074_120116306 | 6.91 |
Slc25a38 |
solute carrier family 25, member 38 |
1201 |
0.24 |
chr14_69324528_69324690 | 6.88 |
Gm16677 |
predicted gene, 16677 |
12473 |
0.09 |
chr14_69542778_69542940 | 6.88 |
Gm27174 |
predicted gene 27174 |
12473 |
0.1 |
chr18_25883486_25883637 | 6.86 |
Gm50304 |
predicted gene, 50304 |
44484 |
0.17 |
chr5_119464736_119465058 | 6.85 |
Gm31314 |
predicted gene, 31314 |
63057 |
0.12 |
chr12_80853693_80853904 | 6.85 |
Susd6 |
sushi domain containing 6 |
14910 |
0.15 |
chr10_87520827_87520978 | 6.85 |
Pah |
phenylalanine hydroxylase |
893 |
0.6 |
chr2_144446471_144446635 | 6.83 |
Zfp133-ps |
zinc finger protein 133, pseudogene |
12727 |
0.15 |
chr6_38834841_38835083 | 6.82 |
Hipk2 |
homeodomain interacting protein kinase 2 |
2262 |
0.35 |
chr7_103813259_103814109 | 6.80 |
Hbb-bt |
hemoglobin, beta adult t chain |
312 |
0.71 |
chr8_13594955_13595106 | 6.79 |
Rasa3 |
RAS p21 protein activator 3 |
10992 |
0.17 |
chr4_132040354_132040528 | 6.79 |
Gm13063 |
predicted gene 13063 |
7737 |
0.12 |
chr14_76673913_76674283 | 6.78 |
1700108F19Rik |
RIKEN cDNA 1700108F19 gene |
1135 |
0.54 |
chr7_127119224_127119375 | 6.78 |
Qprt |
quinolinate phosphoribosyltransferase |
2719 |
0.11 |
chr19_16015785_16015936 | 6.78 |
Rpl37-ps1 |
ribosomal protein 37, pseudogene 1 |
9591 |
0.18 |
chr7_132686585_132686739 | 6.75 |
Gm15582 |
predicted gene 15582 |
26778 |
0.16 |
chr7_90023149_90023335 | 6.74 |
E230029C05Rik |
RIKEN cDNA E230029C05 gene |
5917 |
0.14 |
chr4_54527866_54528026 | 6.73 |
Tpt1-ps2 |
tumor protein, translationally-controlled, pseudogene 2 |
36677 |
0.19 |
chr4_93481257_93481600 | 6.71 |
Gm23443 |
predicted gene, 23443 |
63849 |
0.13 |
chr8_25980319_25980470 | 6.71 |
Hgsnat |
heparan-alpha-glucosaminide N-acetyltransferase |
3641 |
0.16 |
chr7_120868477_120868632 | 6.70 |
Gm15774 |
predicted gene 15774 |
6744 |
0.13 |
chr19_40679012_40679163 | 6.68 |
Entpd1 |
ectonucleoside triphosphate diphosphohydrolase 1 |
2580 |
0.24 |
chr11_104981545_104981696 | 6.67 |
Gm11622 |
predicted gene 11622 |
49537 |
0.11 |
chr8_126846285_126846436 | 6.60 |
A630001O12Rik |
RIKEN cDNA A630001O12 gene |
7127 |
0.21 |
chr7_19224973_19225310 | 6.60 |
Opa3 |
optic atrophy 3 |
3193 |
0.1 |
chr5_5419963_5420114 | 6.59 |
Cdk14 |
cyclin-dependent kinase 14 |
274 |
0.92 |
chr8_10924334_10925220 | 6.59 |
3930402G23Rik |
RIKEN cDNA 3930402G23 gene |
3667 |
0.12 |
chr1_87620165_87620489 | 6.58 |
Inpp5d |
inositol polyphosphate-5-phosphatase D |
15 |
0.97 |
chr4_150566275_150566426 | 6.58 |
Gm13091 |
predicted gene 13091 |
2194 |
0.3 |
chr2_75792475_75792662 | 6.56 |
Gm13657 |
predicted gene 13657 |
15380 |
0.13 |
chr16_3894937_3895088 | 6.55 |
Naa60 |
N(alpha)-acetyltransferase 60, NatF catalytic subunit |
637 |
0.46 |
chr12_98746733_98746999 | 6.55 |
Zc3h14 |
zinc finger CCCH type containing 14 |
98 |
0.95 |
chrX_136060875_136061032 | 6.54 |
Bex2 |
brain expressed X-linked 2 |
7283 |
0.13 |
chr13_49561025_49561228 | 6.50 |
Aspn |
asporin |
16639 |
0.13 |
chr13_119713239_119713438 | 6.48 |
Gm48342 |
predicted gene, 48342 |
8789 |
0.11 |
chr16_21358803_21358980 | 6.48 |
Magef1 |
melanoma antigen family F, 1 |
25535 |
0.17 |
chr3_96263203_96263569 | 6.48 |
H4c14 |
H4 clustered histone 14 |
75 |
0.76 |
chr19_56801371_56801536 | 6.45 |
Ccdc186 |
coiled-coil domain containing 186 |
467 |
0.79 |
chr18_4558907_4559058 | 6.44 |
Gm50024 |
predicted gene, 50024 |
31781 |
0.18 |
chr14_36316822_36316973 | 6.43 |
Gm48663 |
predicted gene, 48663 |
84856 |
0.1 |
chr4_46040663_46041414 | 6.43 |
Tmod1 |
tropomodulin 1 |
1829 |
0.35 |
chr4_86902458_86902781 | 6.41 |
Acer2 |
alkaline ceramidase 2 |
28072 |
0.18 |
chr4_59803498_59803649 | 6.41 |
Inip |
INTS3 and NABP interacting protein |
1984 |
0.26 |
chr14_75180603_75180766 | 6.40 |
Lcp1 |
lymphocyte cytosolic protein 1 |
4476 |
0.18 |
chr19_10842358_10842531 | 6.40 |
Slc15a3 |
solute carrier family 15, member 3 |
100 |
0.88 |
chr6_122863065_122863216 | 6.37 |
C3ar1 |
complement component 3a receptor 1 |
6979 |
0.11 |
chr6_87541091_87541242 | 6.36 |
Gm44198 |
predicted gene, 44198 |
7759 |
0.15 |
chr11_17008646_17008797 | 6.30 |
Plek |
pleckstrin |
19 |
0.97 |
chr6_145303040_145303191 | 6.25 |
2010013B24Rik |
RIKEN cDNA 2010013B24 gene |
37 |
0.94 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.5 | 21.8 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
5.1 | 15.2 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
4.3 | 13.0 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
4.2 | 12.6 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
3.9 | 11.7 | GO:0051665 | membrane raft localization(GO:0051665) |
3.4 | 13.6 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
2.4 | 7.2 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
2.2 | 13.1 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
2.0 | 8.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
2.0 | 6.1 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
1.9 | 1.9 | GO:0039534 | negative regulation of MDA-5 signaling pathway(GO:0039534) |
1.8 | 5.5 | GO:1904690 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
1.8 | 9.2 | GO:0046618 | drug export(GO:0046618) |
1.8 | 5.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
1.8 | 10.9 | GO:0002576 | platelet degranulation(GO:0002576) |
1.8 | 7.2 | GO:1901300 | positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
1.8 | 5.4 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.7 | 6.7 | GO:0050713 | negative regulation of interleukin-1 beta secretion(GO:0050713) |
1.7 | 8.3 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
1.7 | 5.0 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
1.6 | 4.9 | GO:0021564 | vagus nerve development(GO:0021564) |
1.6 | 4.8 | GO:0061091 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
1.5 | 4.6 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
1.5 | 4.5 | GO:2000474 | regulation of opioid receptor signaling pathway(GO:2000474) |
1.5 | 5.9 | GO:1903352 | ornithine transport(GO:0015822) L-ornithine transmembrane transport(GO:1903352) |
1.5 | 4.4 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.4 | 5.6 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
1.4 | 4.1 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
1.4 | 2.7 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
1.3 | 4.0 | GO:0072361 | regulation of glycolytic process by regulation of transcription from RNA polymerase II promoter(GO:0072361) |
1.3 | 2.7 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
1.3 | 5.1 | GO:0034627 | 'de novo' NAD biosynthetic process(GO:0034627) |
1.2 | 4.8 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
1.2 | 3.5 | GO:2000259 | positive regulation of complement activation(GO:0045917) positive regulation of protein activation cascade(GO:2000259) |
1.2 | 5.9 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
1.2 | 8.2 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
1.2 | 10.4 | GO:0035999 | tetrahydrofolate interconversion(GO:0035999) |
1.2 | 5.8 | GO:0010606 | positive regulation of cytoplasmic mRNA processing body assembly(GO:0010606) |
1.1 | 3.4 | GO:2001245 | regulation of phosphatidylcholine biosynthetic process(GO:2001245) |
1.1 | 4.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
1.1 | 5.4 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
1.1 | 9.8 | GO:1900363 | regulation of mRNA polyadenylation(GO:1900363) |
1.1 | 4.3 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
1.1 | 3.2 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
1.1 | 4.2 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
1.1 | 5.3 | GO:0043652 | engulfment of apoptotic cell(GO:0043652) |
1.0 | 1.0 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
1.0 | 3.1 | GO:1900740 | regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900739) positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway(GO:1900740) |
1.0 | 3.1 | GO:1902065 | response to L-glutamate(GO:1902065) |
1.0 | 2.0 | GO:2000152 | regulation of ubiquitin-specific protease activity(GO:2000152) |
1.0 | 4.0 | GO:0042758 | long-chain fatty acid catabolic process(GO:0042758) |
1.0 | 2.0 | GO:0071462 | cellular response to water stimulus(GO:0071462) |
1.0 | 3.0 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
1.0 | 4.0 | GO:0008228 | opsonization(GO:0008228) |
1.0 | 4.9 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
1.0 | 3.9 | GO:0032264 | IMP salvage(GO:0032264) |
1.0 | 2.9 | GO:2001180 | negative regulation of interleukin-10 secretion(GO:2001180) |
1.0 | 2.9 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
0.9 | 2.8 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
0.9 | 3.7 | GO:0030311 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
0.9 | 3.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.9 | 2.8 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.9 | 1.8 | GO:0070947 | neutrophil mediated killing of fungus(GO:0070947) |
0.9 | 2.7 | GO:1903753 | negative regulation of p38MAPK cascade(GO:1903753) |
0.9 | 1.8 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
0.9 | 2.7 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.9 | 7.2 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.9 | 1.8 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
0.9 | 5.2 | GO:0045046 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.9 | 1.7 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.9 | 2.6 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.9 | 6.0 | GO:0019852 | L-ascorbic acid metabolic process(GO:0019852) |
0.9 | 2.6 | GO:0015793 | glycerol transport(GO:0015793) |
0.8 | 4.1 | GO:0042699 | follicle-stimulating hormone signaling pathway(GO:0042699) |
0.8 | 2.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
0.8 | 0.8 | GO:0002538 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) |
0.8 | 3.2 | GO:0010693 | negative regulation of alkaline phosphatase activity(GO:0010693) |
0.8 | 2.4 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.8 | 0.8 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.8 | 4.0 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.8 | 1.6 | GO:0051344 | negative regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051344) |
0.8 | 2.4 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
0.8 | 2.4 | GO:1903238 | positive regulation of leukocyte tethering or rolling(GO:1903238) |
0.8 | 2.4 | GO:0071688 | skeletal muscle myosin thick filament assembly(GO:0030241) striated muscle myosin thick filament assembly(GO:0071688) |
0.8 | 5.5 | GO:0060295 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.8 | 0.8 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
0.8 | 3.8 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.8 | 3.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
0.7 | 1.5 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.7 | 2.9 | GO:0007023 | post-chaperonin tubulin folding pathway(GO:0007023) |
0.7 | 1.5 | GO:2000741 | positive regulation of mesenchymal stem cell differentiation(GO:2000741) |
0.7 | 1.4 | GO:0042364 | water-soluble vitamin biosynthetic process(GO:0042364) |
0.7 | 3.6 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.7 | 4.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.7 | 4.2 | GO:1902222 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.7 | 2.1 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
0.7 | 2.1 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.7 | 1.4 | GO:0046271 | phenylpropanoid catabolic process(GO:0046271) |
0.7 | 1.4 | GO:0032782 | bile acid secretion(GO:0032782) |
0.7 | 3.5 | GO:2000318 | positive regulation of T-helper 17 type immune response(GO:2000318) |
0.7 | 2.1 | GO:1990035 | calcium ion import into cell(GO:1990035) |
0.7 | 0.7 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) |
0.7 | 1.3 | GO:0060125 | negative regulation of growth hormone secretion(GO:0060125) |
0.7 | 1.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.7 | 4.6 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.7 | 5.9 | GO:0071361 | cellular response to ethanol(GO:0071361) |
0.6 | 2.6 | GO:0014012 | peripheral nervous system axon regeneration(GO:0014012) |
0.6 | 2.5 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.6 | 1.3 | GO:0034499 | late endosome to Golgi transport(GO:0034499) |
0.6 | 3.1 | GO:0009992 | cellular water homeostasis(GO:0009992) |
0.6 | 4.4 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
0.6 | 1.9 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.6 | 5.0 | GO:0033262 | regulation of nuclear cell cycle DNA replication(GO:0033262) |
0.6 | 1.2 | GO:0030950 | establishment or maintenance of actin cytoskeleton polarity(GO:0030950) |
0.6 | 2.5 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
0.6 | 5.4 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
0.6 | 2.4 | GO:2000574 | regulation of microtubule motor activity(GO:2000574) |
0.6 | 3.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.6 | 1.8 | GO:0046167 | glycerol-3-phosphate biosynthetic process(GO:0046167) |
0.6 | 1.8 | GO:0006059 | hexitol metabolic process(GO:0006059) |
0.6 | 0.6 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.6 | 0.6 | GO:0035435 | phosphate ion transmembrane transport(GO:0035435) |
0.6 | 2.9 | GO:0051126 | negative regulation of actin nucleation(GO:0051126) |
0.6 | 1.2 | GO:0051081 | membrane disassembly(GO:0030397) nuclear envelope disassembly(GO:0051081) |
0.6 | 4.6 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.6 | 0.6 | GO:0003097 | renal water transport(GO:0003097) |
0.6 | 4.0 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.6 | 0.6 | GO:0043622 | cortical microtubule organization(GO:0043622) |
0.6 | 1.7 | GO:0009826 | unidimensional cell growth(GO:0009826) |
0.6 | 6.7 | GO:1900151 | regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900151) positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay(GO:1900153) |
0.6 | 1.7 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
0.6 | 1.7 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.6 | 7.7 | GO:0006465 | signal peptide processing(GO:0006465) |
0.5 | 1.6 | GO:0002254 | kinin cascade(GO:0002254) |
0.5 | 0.5 | GO:0015819 | lysine transport(GO:0015819) |
0.5 | 2.2 | GO:0044838 | cell quiescence(GO:0044838) |
0.5 | 2.2 | GO:0061620 | glycolytic process through glucose-6-phosphate(GO:0061620) |
0.5 | 4.3 | GO:0046185 | aldehyde catabolic process(GO:0046185) |
0.5 | 1.1 | GO:0070294 | renal sodium ion transport(GO:0003096) renal sodium ion absorption(GO:0070294) |
0.5 | 1.1 | GO:0035790 | platelet-derived growth factor receptor-alpha signaling pathway(GO:0035790) |
0.5 | 2.1 | GO:1900864 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.5 | 13.1 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
0.5 | 1.0 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
0.5 | 0.5 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) |
0.5 | 3.6 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.5 | 1.5 | GO:0071877 | regulation of adrenergic receptor signaling pathway(GO:0071877) |
0.5 | 1.0 | GO:0050904 | diapedesis(GO:0050904) |
0.5 | 2.6 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.5 | 0.5 | GO:0014732 | skeletal muscle atrophy(GO:0014732) |
0.5 | 4.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.5 | 3.5 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.5 | 1.5 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 2.0 | GO:0023021 | termination of signal transduction(GO:0023021) |
0.5 | 1.5 | GO:0035513 | oxidative RNA demethylation(GO:0035513) oxidative single-stranded RNA demethylation(GO:0035553) |
0.5 | 1.0 | GO:0010520 | regulation of reciprocal meiotic recombination(GO:0010520) |
0.5 | 1.5 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.5 | 0.5 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 1.0 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
0.5 | 0.5 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) positive regulation of interleukin-18 production(GO:0032741) |
0.5 | 0.5 | GO:0002513 | tolerance induction to self antigen(GO:0002513) |
0.5 | 2.4 | GO:1902916 | positive regulation of protein polyubiquitination(GO:1902916) |
0.5 | 2.9 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 1.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.5 | 7.1 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
0.5 | 1.4 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.5 | 5.2 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.5 | 2.3 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.5 | 2.3 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
0.5 | 2.3 | GO:0015671 | oxygen transport(GO:0015671) |
0.5 | 0.5 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) |
0.5 | 1.4 | GO:0035973 | aggrephagy(GO:0035973) |
0.5 | 10.1 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 2.7 | GO:0001842 | neural fold formation(GO:0001842) |
0.5 | 1.4 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
0.5 | 1.4 | GO:0032439 | endosome localization(GO:0032439) |
0.4 | 2.2 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
0.4 | 1.3 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.4 | 2.2 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.4 | 1.3 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.4 | 4.4 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.4 | 1.8 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.4 | 0.4 | GO:0010911 | regulation of isomerase activity(GO:0010911) positive regulation of isomerase activity(GO:0010912) |
0.4 | 1.7 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.4 | 1.3 | GO:0042117 | monocyte activation(GO:0042117) |
0.4 | 1.3 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.4 | 2.5 | GO:0051013 | microtubule severing(GO:0051013) |
0.4 | 0.4 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.4 | 1.7 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.4 | 0.4 | GO:0060066 | oviduct development(GO:0060066) |
0.4 | 2.5 | GO:0051639 | actin filament network formation(GO:0051639) |
0.4 | 2.9 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.4 | 1.7 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
0.4 | 7.4 | GO:0071549 | cellular response to dexamethasone stimulus(GO:0071549) |
0.4 | 2.8 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.4 | 0.8 | GO:0006208 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
0.4 | 0.4 | GO:0071698 | olfactory placode formation(GO:0030910) olfactory placode development(GO:0071698) olfactory placode morphogenesis(GO:0071699) |
0.4 | 1.2 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.4 | 1.2 | GO:0097680 | double-strand break repair via classical nonhomologous end joining(GO:0097680) |
0.4 | 0.4 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.4 | 2.0 | GO:0006548 | histidine metabolic process(GO:0006547) histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.4 | 0.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.4 | 0.8 | GO:0061085 | regulation of histone H3-K27 methylation(GO:0061085) |
0.4 | 0.4 | GO:2000316 | regulation of T-helper 17 type immune response(GO:2000316) |
0.4 | 1.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 1.2 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.4 | 1.9 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.4 | 3.5 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.4 | 1.5 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.4 | 1.2 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
0.4 | 5.3 | GO:0060746 | parental behavior(GO:0060746) |
0.4 | 0.8 | GO:0061511 | centriole elongation(GO:0061511) |
0.4 | 2.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.4 | 1.5 | GO:2001013 | epithelial cell proliferation involved in renal tubule morphogenesis(GO:2001013) |
0.4 | 1.1 | GO:0070375 | ERK5 cascade(GO:0070375) |
0.4 | 5.3 | GO:0006907 | pinocytosis(GO:0006907) |
0.4 | 0.4 | GO:0002860 | positive regulation of natural killer cell mediated immune response to tumor cell(GO:0002857) positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002860) |
0.4 | 1.1 | GO:0042256 | mature ribosome assembly(GO:0042256) |
0.4 | 1.9 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.4 | 0.4 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.4 | 1.8 | GO:1902036 | regulation of hematopoietic stem cell differentiation(GO:1902036) |
0.4 | 1.5 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
0.4 | 1.5 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.4 | 1.5 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.4 | 1.1 | GO:1900060 | negative regulation of ceramide biosynthetic process(GO:1900060) |
0.4 | 0.7 | GO:1903984 | regulation of TRAIL-activated apoptotic signaling pathway(GO:1903121) positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
0.4 | 2.9 | GO:0032494 | response to peptidoglycan(GO:0032494) |
0.4 | 1.1 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.4 | 4.0 | GO:0097286 | iron ion import(GO:0097286) |
0.4 | 2.1 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.4 | 1.1 | GO:0009838 | abscission(GO:0009838) |
0.4 | 2.9 | GO:0090266 | regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) regulation of mitotic spindle checkpoint(GO:1903504) |
0.4 | 2.8 | GO:0043249 | erythrocyte maturation(GO:0043249) |
0.4 | 1.1 | GO:0000087 | mitotic M phase(GO:0000087) |
0.4 | 1.8 | GO:0048539 | bone marrow development(GO:0048539) |
0.4 | 1.4 | GO:0090306 | spindle assembly involved in meiosis(GO:0090306) |
0.4 | 1.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.4 | 3.2 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.4 | 2.1 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.4 | 2.1 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
0.3 | 4.2 | GO:0044406 | adhesion of symbiont to host(GO:0044406) |
0.3 | 1.4 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.3 | 1.0 | GO:0090148 | membrane fission(GO:0090148) |
0.3 | 5.2 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 1.7 | GO:0060613 | fat pad development(GO:0060613) |
0.3 | 1.0 | GO:2001170 | negative regulation of ATP biosynthetic process(GO:2001170) |
0.3 | 1.0 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.3 | 3.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.3 | 2.4 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.3 | 1.4 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
0.3 | 1.7 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.3 | 0.3 | GO:1904219 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) regulation of serine C-palmitoyltransferase activity(GO:1904220) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.3 | 4.7 | GO:0070168 | negative regulation of biomineral tissue development(GO:0070168) |
0.3 | 8.7 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.3 | 1.3 | GO:0002913 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.3 | 1.3 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.3 | 5.6 | GO:0006903 | vesicle targeting(GO:0006903) |
0.3 | 1.6 | GO:0014719 | skeletal muscle satellite cell activation(GO:0014719) |
0.3 | 1.0 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.3 | 0.7 | GO:1903689 | regulation of wound healing, spreading of epidermal cells(GO:1903689) |
0.3 | 1.0 | GO:0033015 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) |
0.3 | 1.0 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
0.3 | 2.3 | GO:0090205 | positive regulation of cholesterol biosynthetic process(GO:0045542) positive regulation of cholesterol metabolic process(GO:0090205) |
0.3 | 0.6 | GO:0043201 | response to leucine(GO:0043201) cellular response to leucine(GO:0071233) |
0.3 | 0.6 | GO:0031392 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.3 | 12.8 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) |
0.3 | 0.6 | GO:1901856 | negative regulation of cellular respiration(GO:1901856) |
0.3 | 0.6 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.3 | 1.0 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.3 | 2.5 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.3 | 1.9 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
0.3 | 0.9 | GO:0006578 | amino-acid betaine biosynthetic process(GO:0006578) |
0.3 | 0.3 | GO:0070949 | regulation of neutrophil mediated cytotoxicity(GO:0070948) regulation of neutrophil mediated killing of symbiont cell(GO:0070949) |
0.3 | 0.9 | GO:0061368 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.3 | 1.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.3 | 1.9 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.3 | 0.6 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 1.8 | GO:1904707 | positive regulation of vascular smooth muscle cell proliferation(GO:1904707) |
0.3 | 0.3 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.3 | 1.8 | GO:0000447 | endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000447) |
0.3 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.3 | 1.5 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
0.3 | 0.6 | GO:0070827 | chromatin maintenance(GO:0070827) |
0.3 | 3.6 | GO:0002115 | store-operated calcium entry(GO:0002115) |
0.3 | 0.6 | GO:1902075 | cellular response to salt(GO:1902075) |
0.3 | 1.2 | GO:0015886 | heme transport(GO:0015886) |
0.3 | 0.6 | GO:0036151 | phosphatidylcholine acyl-chain remodeling(GO:0036151) |
0.3 | 2.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.6 | GO:0043309 | regulation of eosinophil degranulation(GO:0043309) |
0.3 | 0.6 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.3 | 0.6 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.3 | 2.1 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.3 | 0.9 | GO:0006624 | vacuolar protein processing(GO:0006624) |
0.3 | 1.8 | GO:0033129 | positive regulation of histone phosphorylation(GO:0033129) |
0.3 | 0.6 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.3 | 0.9 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
0.3 | 2.0 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.3 | 0.6 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.3 | 2.6 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
0.3 | 3.4 | GO:0046697 | decidualization(GO:0046697) |
0.3 | 0.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.3 | 1.4 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 1.1 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.3 | 1.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.3 | 0.8 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.3 | 0.8 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.3 | 0.3 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
0.3 | 0.8 | GO:1903077 | negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
0.3 | 0.5 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
0.3 | 0.5 | GO:0032906 | transforming growth factor beta2 production(GO:0032906) regulation of transforming growth factor beta2 production(GO:0032909) |
0.3 | 0.3 | GO:1903236 | regulation of leukocyte tethering or rolling(GO:1903236) |
0.3 | 1.9 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.3 | 8.7 | GO:0006506 | GPI anchor biosynthetic process(GO:0006506) |
0.3 | 1.4 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.3 | 0.5 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
0.3 | 0.5 | GO:0035962 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.3 | 1.6 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.3 | 0.5 | GO:0036258 | multivesicular body assembly(GO:0036258) |
0.3 | 1.6 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.3 | 1.1 | GO:0003223 | ventricular compact myocardium morphogenesis(GO:0003223) |
0.3 | 2.9 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.3 | 2.7 | GO:0032986 | nucleosome disassembly(GO:0006337) protein-DNA complex disassembly(GO:0032986) |
0.3 | 0.3 | GO:0002579 | positive regulation of antigen processing and presentation(GO:0002579) |
0.3 | 2.1 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
0.3 | 0.5 | GO:1903116 | positive regulation of actin filament-based movement(GO:1903116) |
0.3 | 1.1 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.3 | 0.5 | GO:0033615 | mitochondrial proton-transporting ATP synthase complex assembly(GO:0033615) |
0.3 | 1.6 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.3 | 14.4 | GO:0097192 | signal transduction in absence of ligand(GO:0038034) extrinsic apoptotic signaling pathway in absence of ligand(GO:0097192) |
0.3 | 0.8 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.3 | 1.0 | GO:0007296 | vitellogenesis(GO:0007296) |
0.3 | 0.5 | GO:0002215 | defense response to nematode(GO:0002215) |
0.3 | 0.8 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.3 | 2.8 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.3 | 1.5 | GO:0006198 | cAMP catabolic process(GO:0006198) |
0.3 | 1.5 | GO:2001275 | positive regulation of glucose import in response to insulin stimulus(GO:2001275) |
0.3 | 0.8 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.3 | 0.5 | GO:0036394 | amylase secretion(GO:0036394) |
0.2 | 2.0 | GO:0046641 | positive regulation of alpha-beta T cell proliferation(GO:0046641) |
0.2 | 0.7 | GO:1901843 | positive regulation of high voltage-gated calcium channel activity(GO:1901843) |
0.2 | 1.7 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.2 | 0.5 | GO:0070340 | detection of bacterial lipopeptide(GO:0070340) |
0.2 | 2.0 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.2 | 0.2 | GO:0042536 | negative regulation of tumor necrosis factor biosynthetic process(GO:0042536) |
0.2 | 0.2 | GO:1901419 | regulation of response to alcohol(GO:1901419) |
0.2 | 1.2 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.2 | 1.7 | GO:0031573 | intra-S DNA damage checkpoint(GO:0031573) |
0.2 | 0.2 | GO:0060700 | regulation of ribonuclease activity(GO:0060700) |
0.2 | 0.2 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.2 | 0.5 | GO:0046439 | cysteine catabolic process(GO:0009093) L-cysteine catabolic process(GO:0019448) L-cysteine metabolic process(GO:0046439) |
0.2 | 0.2 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.2 | 1.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.2 | 0.7 | GO:0002309 | T cell proliferation involved in immune response(GO:0002309) |
0.2 | 1.0 | GO:0048478 | replication fork protection(GO:0048478) |
0.2 | 0.2 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
0.2 | 0.2 | GO:0043308 | eosinophil activation involved in immune response(GO:0002278) eosinophil mediated immunity(GO:0002447) eosinophil degranulation(GO:0043308) |
0.2 | 1.2 | GO:0016266 | O-glycan processing(GO:0016266) |
0.2 | 2.3 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
0.2 | 0.2 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.7 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
0.2 | 1.6 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.7 | GO:0060318 | definitive erythrocyte differentiation(GO:0060318) |
0.2 | 1.6 | GO:0015868 | purine ribonucleotide transport(GO:0015868) |
0.2 | 1.4 | GO:0039529 | RIG-I signaling pathway(GO:0039529) |
0.2 | 0.4 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.2 | 1.3 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.2 | 0.2 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.2 | 0.7 | GO:1902373 | negative regulation of mRNA catabolic process(GO:1902373) regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.2 | 0.7 | GO:0036297 | interstrand cross-link repair(GO:0036297) |
0.2 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.2 | 0.4 | GO:1904124 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
0.2 | 4.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.2 | 0.7 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.2 | 1.8 | GO:0051152 | positive regulation of smooth muscle cell differentiation(GO:0051152) |
0.2 | 5.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.2 | 0.2 | GO:0061724 | lipophagy(GO:0061724) |
0.2 | 0.2 | GO:0034241 | positive regulation of macrophage fusion(GO:0034241) |
0.2 | 0.7 | GO:2001182 | regulation of interleukin-12 secretion(GO:2001182) |
0.2 | 2.8 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.2 | 0.9 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.6 | GO:0006106 | fumarate metabolic process(GO:0006106) |
0.2 | 1.5 | GO:0006670 | sphingosine metabolic process(GO:0006670) diol metabolic process(GO:0034311) |
0.2 | 0.4 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.2 | 0.4 | GO:0034374 | low-density lipoprotein particle remodeling(GO:0034374) |
0.2 | 0.4 | GO:0072144 | glomerular mesangial cell differentiation(GO:0072008) glomerular mesangial cell development(GO:0072144) |
0.2 | 0.4 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.2 | 1.7 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
0.2 | 0.4 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
0.2 | 2.1 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
0.2 | 0.4 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 0.4 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.2 | 0.8 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.2 | 0.4 | GO:0052803 | imidazole-containing compound metabolic process(GO:0052803) |
0.2 | 0.8 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.2 | 0.6 | GO:0061010 | gall bladder development(GO:0061010) |
0.2 | 0.6 | GO:0070649 | formin-nucleated actin cable assembly(GO:0070649) |
0.2 | 1.8 | GO:2000269 | regulation of fibroblast apoptotic process(GO:2000269) |
0.2 | 0.6 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.2 | 2.2 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
0.2 | 1.4 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.2 | 1.0 | GO:0071493 | cellular response to UV-B(GO:0071493) |
0.2 | 0.6 | GO:0015888 | thiamine transport(GO:0015888) |
0.2 | 1.0 | GO:0044252 | negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.2 | 2.6 | GO:0042036 | negative regulation of cytokine biosynthetic process(GO:0042036) |
0.2 | 0.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.4 | GO:0031033 | myosin filament organization(GO:0031033) |
0.2 | 2.2 | GO:0010832 | negative regulation of myotube differentiation(GO:0010832) |
0.2 | 0.6 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.2 | 0.2 | GO:0060056 | mammary gland involution(GO:0060056) |
0.2 | 0.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
0.2 | 2.0 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.2 | 0.2 | GO:0071043 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.2 | 3.9 | GO:0034198 | cellular response to amino acid starvation(GO:0034198) |
0.2 | 5.0 | GO:0043550 | regulation of lipid kinase activity(GO:0043550) |
0.2 | 1.7 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.2 | 1.5 | GO:0043649 | dicarboxylic acid catabolic process(GO:0043649) |
0.2 | 5.0 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.2 | 0.4 | GO:0000303 | response to superoxide(GO:0000303) |
0.2 | 0.2 | GO:0002439 | chronic inflammatory response to antigenic stimulus(GO:0002439) |
0.2 | 0.6 | GO:0010360 | negative regulation of anion channel activity(GO:0010360) |
0.2 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 1.0 | GO:0002488 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of endogenous peptide antigen via MHC class Ib(GO:0002476) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway(GO:0002488) antigen processing and presentation of endogenous peptide antigen via MHC class Ib via ER pathway, TAP-dependent(GO:0002489) positive regulation of antigen processing and presentation of peptide antigen(GO:0002585) positive regulation of antigen processing and presentation of peptide antigen via MHC class I(GO:0002591) |
0.2 | 0.6 | GO:0002949 | tRNA threonylcarbamoyladenosine modification(GO:0002949) |
0.2 | 1.0 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
0.2 | 0.2 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
0.2 | 1.9 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.2 | 0.4 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.2 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.2 | 0.4 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 1.1 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
0.2 | 0.8 | GO:0046490 | isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.4 | GO:0090026 | positive regulation of monocyte chemotaxis(GO:0090026) |
0.2 | 0.4 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.2 | 0.6 | GO:1901475 | pyruvate transmembrane transport(GO:1901475) |
0.2 | 1.3 | GO:0032148 | activation of protein kinase B activity(GO:0032148) |
0.2 | 1.5 | GO:0048311 | mitochondrion distribution(GO:0048311) |
0.2 | 1.1 | GO:0070544 | histone H3-K36 demethylation(GO:0070544) |
0.2 | 0.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.2 | GO:0060978 | angiogenesis involved in coronary vascular morphogenesis(GO:0060978) |
0.2 | 0.2 | GO:2000327 | regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000325) positive regulation of ligand-dependent nuclear receptor transcription coactivator activity(GO:2000327) |
0.2 | 0.5 | GO:0001807 | regulation of type IV hypersensitivity(GO:0001807) |
0.2 | 0.9 | GO:0018377 | protein myristoylation(GO:0018377) |
0.2 | 2.4 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.2 | 0.7 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.2 | 0.5 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.2 | 0.2 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
0.2 | 0.5 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.2 | 0.5 | GO:0034441 | plasma lipoprotein particle oxidation(GO:0034441) |
0.2 | 0.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
0.2 | 1.1 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.2 | 1.3 | GO:0070234 | positive regulation of T cell apoptotic process(GO:0070234) |
0.2 | 0.4 | GO:0006068 | ethanol catabolic process(GO:0006068) |
0.2 | 0.9 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.7 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.2 | 3.6 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.2 | 0.5 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.2 | 0.9 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.2 | 0.4 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
0.2 | 0.7 | GO:0003418 | growth plate cartilage chondrocyte differentiation(GO:0003418) |
0.2 | 0.2 | GO:2000138 | positive regulation of cell proliferation involved in heart morphogenesis(GO:2000138) |
0.2 | 3.0 | GO:0006301 | postreplication repair(GO:0006301) |
0.2 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.2 | 0.7 | GO:0071684 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
0.2 | 1.9 | GO:0010390 | histone monoubiquitination(GO:0010390) |
0.2 | 0.7 | GO:0051031 | tRNA transport(GO:0051031) |
0.2 | 1.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.2 | 1.2 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
0.2 | 1.6 | GO:0006390 | transcription from mitochondrial promoter(GO:0006390) |
0.2 | 0.7 | GO:0046909 | intermembrane transport(GO:0046909) |
0.2 | 0.9 | GO:0071569 | protein ufmylation(GO:0071569) |
0.2 | 0.5 | GO:0039689 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.2 | 3.3 | GO:0006911 | phagocytosis, engulfment(GO:0006911) |
0.2 | 6.5 | GO:0045576 | mast cell activation(GO:0045576) |
0.2 | 0.7 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.2 | 1.7 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.2 | 2.5 | GO:0032012 | ARF protein signal transduction(GO:0032011) regulation of ARF protein signal transduction(GO:0032012) |
0.2 | 0.2 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.2 | 1.0 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.2 | 0.3 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.2 | 1.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.2 | 0.3 | GO:0003340 | negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003340) |
0.2 | 1.3 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.2 | 0.7 | GO:0021960 | anterior commissure morphogenesis(GO:0021960) |
0.2 | 1.0 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.2 | 0.2 | GO:0046321 | positive regulation of fatty acid oxidation(GO:0046321) |
0.2 | 1.2 | GO:0009074 | aromatic amino acid family catabolic process(GO:0009074) |
0.2 | 0.5 | GO:0009173 | UMP biosynthetic process(GO:0006222) pyrimidine ribonucleoside monophosphate metabolic process(GO:0009173) pyrimidine ribonucleoside monophosphate biosynthetic process(GO:0009174) UMP metabolic process(GO:0046049) |
0.2 | 0.8 | GO:0006884 | cell volume homeostasis(GO:0006884) |
0.2 | 0.3 | GO:0010643 | cell communication by chemical coupling(GO:0010643) |
0.2 | 1.3 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
0.2 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.2 | 0.2 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.2 | 0.2 | GO:0002432 | granuloma formation(GO:0002432) |
0.2 | 0.3 | GO:0046016 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) positive regulation of transcription by glucose(GO:0046016) |
0.2 | 1.1 | GO:0050779 | RNA destabilization(GO:0050779) |
0.2 | 0.2 | GO:1900377 | negative regulation of melanin biosynthetic process(GO:0048022) negative regulation of secondary metabolite biosynthetic process(GO:1900377) |
0.2 | 2.7 | GO:0032981 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.2 | 0.5 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
0.2 | 0.5 | GO:1903061 | positive regulation of protein lipidation(GO:1903061) |
0.2 | 3.4 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.2 | 1.4 | GO:0030238 | male sex determination(GO:0030238) |
0.2 | 1.4 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.2 | 0.3 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.2 | 0.6 | GO:0014912 | negative regulation of smooth muscle cell migration(GO:0014912) |
0.2 | 0.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 5.6 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.2 | 0.2 | GO:0035376 | sterol import(GO:0035376) cholesterol import(GO:0070508) |
0.2 | 0.6 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.2 | 0.3 | GO:0097343 | ripoptosome assembly(GO:0097343) ripoptosome assembly involved in necroptotic process(GO:1901026) |
0.2 | 0.5 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.2 | 0.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.2 | 0.3 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.2 | 8.8 | GO:0019724 | B cell mediated immunity(GO:0019724) |
0.2 | 1.6 | GO:0006895 | Golgi to endosome transport(GO:0006895) |
0.2 | 0.8 | GO:0090043 | tubulin deacetylation(GO:0090042) regulation of tubulin deacetylation(GO:0090043) |
0.2 | 0.5 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.2 | 1.7 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
0.2 | 0.2 | GO:1902219 | intrinsic apoptotic signaling pathway in response to osmotic stress(GO:0008627) regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.2 | 0.5 | GO:0044854 | plasma membrane raft assembly(GO:0044854) plasma membrane raft organization(GO:0044857) |
0.2 | 1.4 | GO:0046686 | response to cadmium ion(GO:0046686) |
0.2 | 0.6 | GO:0070127 | tRNA aminoacylation for mitochondrial protein translation(GO:0070127) |
0.2 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.2 | 2.3 | GO:0034243 | regulation of transcription elongation from RNA polymerase II promoter(GO:0034243) |
0.2 | 0.5 | GO:0018214 | peptidyl-glutamic acid carboxylation(GO:0017187) protein carboxylation(GO:0018214) |
0.2 | 1.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.2 | 1.7 | GO:0051497 | negative regulation of stress fiber assembly(GO:0051497) |
0.2 | 2.5 | GO:0015936 | coenzyme A metabolic process(GO:0015936) |
0.2 | 4.3 | GO:0051568 | histone H3-K4 methylation(GO:0051568) |
0.2 | 0.3 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.2 | 0.5 | GO:0044339 | canonical Wnt signaling pathway involved in osteoblast differentiation(GO:0044339) |
0.2 | 0.3 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 0.2 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.2 | 0.3 | GO:2001044 | regulation of integrin-mediated signaling pathway(GO:2001044) |
0.2 | 1.2 | GO:0030220 | platelet formation(GO:0030220) |
0.2 | 0.2 | GO:0071481 | cellular response to X-ray(GO:0071481) |
0.2 | 0.3 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.2 | 0.8 | GO:0048680 | positive regulation of axon regeneration(GO:0048680) |
0.2 | 0.3 | GO:0045630 | positive regulation of T-helper 2 cell differentiation(GO:0045630) |
0.2 | 3.9 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.2 | 0.9 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.2 | 0.3 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.1 | 0.4 | GO:0030327 | prenylated protein catabolic process(GO:0030327) |
0.1 | 0.6 | GO:0015879 | carnitine transport(GO:0015879) |
0.1 | 0.3 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
0.1 | 0.4 | GO:0015770 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.3 | GO:0046931 | pore complex assembly(GO:0046931) |
0.1 | 0.4 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 3.5 | GO:0000956 | nuclear-transcribed mRNA catabolic process(GO:0000956) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.1 | 0.1 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
0.1 | 0.3 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.1 | 1.4 | GO:0000470 | maturation of LSU-rRNA(GO:0000470) |
0.1 | 6.0 | GO:0030593 | neutrophil chemotaxis(GO:0030593) |
0.1 | 1.3 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.1 | 0.3 | GO:0090085 | regulation of protein deubiquitination(GO:0090085) |
0.1 | 0.1 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.1 | 0.7 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.1 | 4.6 | GO:0061045 | negative regulation of wound healing(GO:0061045) |
0.1 | 0.6 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.3 | GO:0060155 | platelet dense granule organization(GO:0060155) |
0.1 | 3.9 | GO:0046488 | phosphatidylinositol metabolic process(GO:0046488) |
0.1 | 0.3 | GO:0002580 | regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002580) negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) regulation of antigen processing and presentation of peptide antigen via MHC class II(GO:0002586) |
0.1 | 3.1 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.7 | GO:0043084 | penile erection(GO:0043084) |
0.1 | 4.7 | GO:0072583 | clathrin-mediated endocytosis(GO:0072583) |
0.1 | 1.4 | GO:0007213 | G-protein coupled acetylcholine receptor signaling pathway(GO:0007213) |
0.1 | 2.1 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.1 | 0.6 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.1 | 0.3 | GO:1901841 | regulation of high voltage-gated calcium channel activity(GO:1901841) |
0.1 | 0.3 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.1 | 0.3 | GO:0001302 | replicative cell aging(GO:0001302) |
0.1 | 5.5 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.1 | 0.3 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.3 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.1 | 0.4 | GO:0007525 | somatic muscle development(GO:0007525) |
0.1 | 1.7 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.1 | 0.9 | GO:0046415 | urate metabolic process(GO:0046415) |
0.1 | 0.9 | GO:0032506 | cytokinetic process(GO:0032506) |
0.1 | 1.1 | GO:1902235 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902235) |
0.1 | 1.7 | GO:0050686 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) negative regulation of mRNA processing(GO:0050686) |
0.1 | 0.8 | GO:0010668 | ectodermal cell differentiation(GO:0010668) |
0.1 | 1.1 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
0.1 | 0.1 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.1 | 0.1 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.1 | 1.2 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
0.1 | 0.1 | GO:2000383 | regulation of ectoderm development(GO:2000383) negative regulation of ectoderm development(GO:2000384) |
0.1 | 0.1 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
0.1 | 1.3 | GO:0006120 | mitochondrial electron transport, NADH to ubiquinone(GO:0006120) |
0.1 | 0.1 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.1 | 0.1 | GO:0033280 | response to vitamin D(GO:0033280) |
0.1 | 1.6 | GO:0045661 | regulation of myoblast differentiation(GO:0045661) |
0.1 | 1.6 | GO:0006525 | arginine metabolic process(GO:0006525) |
0.1 | 1.9 | GO:0006879 | cellular iron ion homeostasis(GO:0006879) |
0.1 | 1.0 | GO:0045909 | positive regulation of vasodilation(GO:0045909) |
0.1 | 0.8 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.1 | GO:1990791 | dorsal root ganglion development(GO:1990791) |
0.1 | 0.1 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.1 | 0.5 | GO:0006244 | pyrimidine nucleotide catabolic process(GO:0006244) |
0.1 | 2.4 | GO:0016925 | protein sumoylation(GO:0016925) |
0.1 | 0.5 | GO:0048242 | epinephrine secretion(GO:0048242) |
0.1 | 2.4 | GO:0034605 | cellular response to heat(GO:0034605) |
0.1 | 0.3 | GO:0010796 | regulation of multivesicular body size(GO:0010796) |
0.1 | 0.1 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.1 | 0.3 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.5 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
0.1 | 0.6 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.3 | GO:0001922 | B-1 B cell homeostasis(GO:0001922) |
0.1 | 0.3 | GO:1903301 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.5 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.4 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
0.1 | 0.4 | GO:2000615 | regulation of histone H3-K9 acetylation(GO:2000615) |
0.1 | 0.3 | GO:0046600 | negative regulation of centriole replication(GO:0046600) |
0.1 | 0.7 | GO:0071267 | amino acid salvage(GO:0043102) L-methionine biosynthetic process(GO:0071265) L-methionine salvage(GO:0071267) |
0.1 | 0.2 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.1 | 2.2 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.1 | 0.2 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
0.1 | 0.4 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.1 | 0.5 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.8 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.7 | GO:0002861 | regulation of inflammatory response to antigenic stimulus(GO:0002861) |
0.1 | 0.5 | GO:0018101 | protein citrullination(GO:0018101) |
0.1 | 0.1 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
0.1 | 3.7 | GO:0032024 | positive regulation of insulin secretion(GO:0032024) |
0.1 | 0.6 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 1.8 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.1 | 0.6 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.1 | 0.4 | GO:0030638 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.1 | 0.2 | GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061418) |
0.1 | 0.5 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.1 | 0.1 | GO:1904816 | positive regulation of protein localization to chromosome, telomeric region(GO:1904816) |
0.1 | 1.5 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.1 | 0.2 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.1 | 1.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.1 | 1.6 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.1 | 0.5 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.1 | 0.1 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 0.6 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.1 | 0.2 | GO:0016237 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
0.1 | 0.1 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.6 | GO:0019432 | triglyceride biosynthetic process(GO:0019432) |
0.1 | 0.2 | GO:0006999 | nuclear pore organization(GO:0006999) |
0.1 | 0.6 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.1 | 1.7 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.1 | 0.3 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.1 | GO:0002858 | natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002420) natural killer cell mediated immune response to tumor cell(GO:0002423) regulation of natural killer cell mediated immune response to tumor cell(GO:0002855) regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002858) |
0.1 | 0.1 | GO:2000224 | regulation of testosterone biosynthetic process(GO:2000224) |
0.1 | 0.7 | GO:0014741 | negative regulation of muscle hypertrophy(GO:0014741) |
0.1 | 0.6 | GO:0007097 | nuclear migration(GO:0007097) |
0.1 | 0.1 | GO:1902302 | regulation of potassium ion export(GO:1902302) |
0.1 | 0.6 | GO:2000643 | positive regulation of early endosome to late endosome transport(GO:2000643) |
0.1 | 0.6 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 2.3 | GO:0042755 | eating behavior(GO:0042755) |
0.1 | 0.2 | GO:1901224 | positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
0.1 | 0.9 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.1 | 0.2 | GO:0035609 | C-terminal protein deglutamylation(GO:0035609) |
0.1 | 0.9 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 0.2 | GO:1903894 | regulation of IRE1-mediated unfolded protein response(GO:1903894) |
0.1 | 0.9 | GO:0052697 | xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.6 | GO:0031365 | N-terminal protein amino acid modification(GO:0031365) |
0.1 | 1.5 | GO:2000272 | negative regulation of receptor activity(GO:2000272) |
0.1 | 0.6 | GO:1904293 | negative regulation of ERAD pathway(GO:1904293) |
0.1 | 0.1 | GO:0032815 | negative regulation of natural killer cell activation(GO:0032815) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.1 | 0.1 | GO:0060926 | cardiac pacemaker cell development(GO:0060926) |
0.1 | 0.3 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
0.1 | 0.3 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
0.1 | 0.2 | GO:0097242 | beta-amyloid clearance(GO:0097242) |
0.1 | 0.6 | GO:0060390 | regulation of SMAD protein import into nucleus(GO:0060390) |
0.1 | 1.2 | GO:1902808 | positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.1 | 0.1 | GO:0070945 | neutrophil mediated killing of gram-negative bacterium(GO:0070945) |
0.1 | 1.2 | GO:0045445 | myoblast differentiation(GO:0045445) |
0.1 | 0.3 | GO:0035426 | extracellular matrix-cell signaling(GO:0035426) |
0.1 | 0.1 | GO:2001273 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.1 | 0.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.2 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.1 | 0.3 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.4 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
0.1 | 0.3 | GO:0045953 | negative regulation of natural killer cell mediated cytotoxicity(GO:0045953) |
0.1 | 0.7 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.1 | 0.4 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) peptidyl-histidine modification(GO:0018202) |
0.1 | 0.9 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 0.3 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.1 | GO:1903797 | regulation of inorganic anion transmembrane transport(GO:1903795) positive regulation of inorganic anion transmembrane transport(GO:1903797) |
0.1 | 1.1 | GO:0048490 | anterograde synaptic vesicle transport(GO:0048490) synaptic vesicle cytoskeletal transport(GO:0099514) synaptic vesicle transport along microtubule(GO:0099517) |
0.1 | 0.2 | GO:0030997 | regulation of centriole-centriole cohesion(GO:0030997) |
0.1 | 0.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.1 | 0.4 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.1 | 0.3 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.1 | 4.3 | GO:0051225 | spindle assembly(GO:0051225) |
0.1 | 0.1 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.1 | 0.4 | GO:0051014 | actin filament severing(GO:0051014) |
0.1 | 0.2 | GO:0001765 | membrane raft assembly(GO:0001765) |
0.1 | 0.1 | GO:0006007 | glucose catabolic process(GO:0006007) |
0.1 | 0.2 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.1 | 0.2 | GO:0035356 | cellular triglyceride homeostasis(GO:0035356) |
0.1 | 3.6 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.1 | 0.4 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.1 | 1.3 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.1 | 1.5 | GO:1901264 | carbohydrate derivative transport(GO:1901264) |
0.1 | 0.4 | GO:0048671 | negative regulation of collateral sprouting(GO:0048671) |
0.1 | 0.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
0.1 | 0.8 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.1 | 0.2 | GO:1904742 | regulation of telomeric DNA binding(GO:1904742) |
0.1 | 0.1 | GO:0032621 | interleukin-18 production(GO:0032621) |
0.1 | 0.3 | GO:0050732 | negative regulation of peptidyl-tyrosine phosphorylation(GO:0050732) |
0.1 | 0.5 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.1 | 2.1 | GO:0009408 | response to heat(GO:0009408) |
0.1 | 0.1 | GO:1903010 | regulation of bone development(GO:1903010) |
0.1 | 0.4 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.1 | 0.1 | GO:0045624 | positive regulation of T-helper cell differentiation(GO:0045624) |
0.1 | 3.7 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.1 | 1.8 | GO:0019915 | lipid storage(GO:0019915) |
0.1 | 0.8 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.1 | 0.5 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
0.1 | 1.2 | GO:0008272 | sulfate transport(GO:0008272) |
0.1 | 0.3 | GO:0032482 | Rab protein signal transduction(GO:0032482) |
0.1 | 0.3 | GO:1904491 | protein localization to ciliary transition zone(GO:1904491) |
0.1 | 0.8 | GO:0042574 | retinal metabolic process(GO:0042574) |
0.1 | 0.1 | GO:0035054 | embryonic heart tube anterior/posterior pattern specification(GO:0035054) |
0.1 | 0.7 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 1.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.3 | GO:0071354 | cellular response to interleukin-6(GO:0071354) |
0.1 | 0.1 | GO:0034136 | negative regulation of toll-like receptor 2 signaling pathway(GO:0034136) |
0.1 | 0.3 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.1 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
0.1 | 2.1 | GO:0060325 | face morphogenesis(GO:0060325) |
0.1 | 0.3 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.1 | 1.1 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
0.1 | 0.3 | GO:2000766 | negative regulation of cytoplasmic translation(GO:2000766) |
0.1 | 0.1 | GO:0051342 | regulation of cyclic-nucleotide phosphodiesterase activity(GO:0051342) |
0.1 | 0.2 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
0.1 | 0.2 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.1 | 0.2 | GO:2000121 | regulation of removal of superoxide radicals(GO:2000121) |
0.1 | 0.3 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 0.7 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.1 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.1 | 0.1 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.1 | 0.2 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
0.1 | 0.1 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.2 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
0.1 | 0.2 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.1 | GO:0090210 | regulation of establishment of blood-brain barrier(GO:0090210) |
0.1 | 1.6 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.1 | 0.4 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 0.2 | GO:1903286 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) regulation of potassium ion import(GO:1903286) positive regulation of potassium ion import(GO:1903288) |
0.1 | 0.1 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
0.1 | 0.2 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.1 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
0.1 | 0.6 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.1 | 0.2 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.1 | 0.2 | GO:0071374 | cellular response to parathyroid hormone stimulus(GO:0071374) |
0.1 | 0.6 | GO:0021702 | cerebellar Purkinje cell differentiation(GO:0021702) |
0.1 | 0.1 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
0.1 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.1 | 0.3 | GO:0009128 | purine nucleoside monophosphate catabolic process(GO:0009128) |
0.1 | 0.2 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.1 | 0.6 | GO:0051457 | maintenance of protein location in nucleus(GO:0051457) |
0.1 | 0.6 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.1 | 1.2 | GO:0035116 | embryonic hindlimb morphogenesis(GO:0035116) |
0.1 | 1.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.1 | 0.4 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.1 | 0.4 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.1 | 0.2 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.1 | 0.1 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.8 | GO:0060261 | positive regulation of transcription initiation from RNA polymerase II promoter(GO:0060261) |
0.1 | 0.2 | GO:0045591 | positive regulation of regulatory T cell differentiation(GO:0045591) |
0.1 | 0.1 | GO:0070889 | platelet alpha granule organization(GO:0070889) |
0.1 | 0.2 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.1 | 0.3 | GO:0061179 | negative regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0061179) |
0.1 | 0.4 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.1 | 0.2 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.1 | GO:0030576 | Cajal body organization(GO:0030576) |
0.1 | 0.5 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.1 | 0.4 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.2 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.1 | 0.1 | GO:0001806 | type IV hypersensitivity(GO:0001806) |
0.1 | 0.1 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.1 | 0.1 | GO:0016479 | negative regulation of transcription from RNA polymerase I promoter(GO:0016479) |
0.1 | 0.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
0.1 | 0.1 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 1.7 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
0.1 | 2.5 | GO:0072332 | intrinsic apoptotic signaling pathway by p53 class mediator(GO:0072332) |
0.1 | 0.5 | GO:2000780 | negative regulation of DNA repair(GO:0045738) negative regulation of double-strand break repair(GO:2000780) |
0.1 | 0.4 | GO:0036514 | dopaminergic neuron axon guidance(GO:0036514) planar cell polarity pathway involved in axon guidance(GO:1904938) |
0.1 | 0.2 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 1.2 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.1 | 0.7 | GO:0007342 | fusion of sperm to egg plasma membrane(GO:0007342) |
0.1 | 0.2 | GO:0001839 | neural plate morphogenesis(GO:0001839) |
0.1 | 0.1 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
0.1 | 0.3 | GO:0045040 | protein import into mitochondrial outer membrane(GO:0045040) |
0.1 | 2.6 | GO:0006405 | RNA export from nucleus(GO:0006405) |
0.1 | 0.1 | GO:0006505 | GPI anchor metabolic process(GO:0006505) |
0.1 | 0.4 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.3 | GO:0006098 | pentose-phosphate shunt(GO:0006098) |
0.1 | 0.1 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.1 | 0.3 | GO:0002690 | positive regulation of leukocyte chemotaxis(GO:0002690) |
0.1 | 0.1 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.2 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.2 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.1 | 0.3 | GO:0061515 | myeloid cell development(GO:0061515) |
0.1 | 0.4 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
0.1 | 0.7 | GO:0051491 | positive regulation of filopodium assembly(GO:0051491) |
0.1 | 0.1 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.8 | GO:0009812 | flavonoid metabolic process(GO:0009812) |
0.1 | 0.2 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.1 | 0.2 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.1 | 0.2 | GO:0035523 | protein K29-linked deubiquitination(GO:0035523) protein K33-linked deubiquitination(GO:1990168) |
0.1 | 0.1 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.4 | GO:0014807 | regulation of somitogenesis(GO:0014807) |
0.1 | 0.3 | GO:0032098 | regulation of appetite(GO:0032098) |
0.1 | 0.2 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.1 | 0.2 | GO:0070874 | negative regulation of glycogen metabolic process(GO:0070874) |
0.1 | 0.9 | GO:2000311 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000311) |
0.1 | 0.1 | GO:0006477 | protein sulfation(GO:0006477) |
0.1 | 0.1 | GO:0045649 | regulation of macrophage differentiation(GO:0045649) |
0.1 | 0.2 | GO:0046950 | cellular ketone body metabolic process(GO:0046950) |
0.1 | 0.3 | GO:0015015 | heparan sulfate proteoglycan biosynthetic process, enzymatic modification(GO:0015015) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.1 | 0.1 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.2 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.1 | 0.2 | GO:0003105 | negative regulation of glomerular filtration(GO:0003105) |
0.1 | 0.1 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 0.8 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
0.1 | 0.3 | GO:0006621 | protein retention in ER lumen(GO:0006621) maintenance of protein localization in endoplasmic reticulum(GO:0035437) |
0.1 | 0.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.1 | 0.1 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.1 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.1 | 0.6 | GO:0070232 | regulation of T cell apoptotic process(GO:0070232) |
0.1 | 1.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 0.1 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
0.1 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.4 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.1 | 1.0 | GO:0070527 | platelet aggregation(GO:0070527) |
0.1 | 0.1 | GO:0040023 | establishment of nucleus localization(GO:0040023) |
0.1 | 0.2 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.1 | 0.3 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 0.2 | GO:2000535 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
0.1 | 0.1 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.1 | 0.2 | GO:0015871 | choline transport(GO:0015871) |
0.1 | 0.3 | GO:0009648 | photoperiodism(GO:0009648) |
0.1 | 0.2 | GO:0033160 | positive regulation of protein import into nucleus, translocation(GO:0033160) |
0.1 | 0.7 | GO:0034505 | tooth mineralization(GO:0034505) |
0.1 | 0.3 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.1 | 0.2 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.1 | 0.2 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) |
0.1 | 1.1 | GO:0006953 | acute-phase response(GO:0006953) |
0.1 | 0.1 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.1 | 0.2 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.3 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.1 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.1 | 0.1 | GO:0010481 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.7 | GO:0060612 | adipose tissue development(GO:0060612) |
0.1 | 0.5 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.1 | 0.2 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
0.1 | 4.3 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.1 | 0.8 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.3 | GO:0000460 | maturation of 5.8S rRNA(GO:0000460) |
0.1 | 0.1 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
0.1 | 0.2 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.1 | 0.2 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.1 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.3 | GO:0000038 | very long-chain fatty acid metabolic process(GO:0000038) |
0.1 | 0.1 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.1 | 0.8 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.1 | 0.4 | GO:0006744 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) quinone biosynthetic process(GO:1901663) |
0.1 | 0.6 | GO:0071166 | ribonucleoprotein complex localization(GO:0071166) |
0.1 | 0.2 | GO:0070417 | cellular response to cold(GO:0070417) |
0.1 | 1.1 | GO:0032922 | circadian regulation of gene expression(GO:0032922) |
0.1 | 0.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
0.1 | 0.1 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.7 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
0.1 | 0.6 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0007621 | negative regulation of female receptivity(GO:0007621) |
0.1 | 0.1 | GO:0070813 | hydrogen sulfide metabolic process(GO:0070813) |
0.1 | 0.1 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.2 | GO:0017062 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.1 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.1 | 0.7 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.4 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.2 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.2 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.1 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.3 | GO:0006107 | oxaloacetate metabolic process(GO:0006107) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:1901187 | regulation of ephrin receptor signaling pathway(GO:1901187) |
0.1 | 0.3 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.3 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.1 | 3.0 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.2 | GO:0051443 | positive regulation of ubiquitin-protein transferase activity(GO:0051443) |
0.1 | 0.1 | GO:0014056 | acetylcholine secretion, neurotransmission(GO:0014055) regulation of acetylcholine secretion, neurotransmission(GO:0014056) |
0.1 | 0.5 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.4 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.1 | 0.2 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.3 | GO:0010818 | T cell chemotaxis(GO:0010818) |
0.1 | 0.1 | GO:0002248 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.1 | 0.1 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.1 | 0.1 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.1 | 1.0 | GO:0006446 | regulation of translational initiation(GO:0006446) |
0.1 | 0.1 | GO:0050651 | dermatan sulfate proteoglycan biosynthetic process(GO:0050651) |
0.1 | 0.2 | GO:0034435 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
0.1 | 0.1 | GO:1902902 | negative regulation of autophagosome assembly(GO:1902902) |
0.1 | 0.1 | GO:0060492 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.1 | 0.1 | GO:0014049 | positive regulation of glutamate secretion(GO:0014049) |
0.1 | 0.7 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.1 | 0.5 | GO:2000249 | regulation of actin cytoskeleton reorganization(GO:2000249) |
0.1 | 0.2 | GO:0021854 | hypothalamus development(GO:0021854) |
0.1 | 1.7 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 0.4 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.1 | 0.3 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.1 | 0.1 | GO:0060022 | hard palate development(GO:0060022) |
0.1 | 0.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.1 | 0.1 | GO:2000258 | negative regulation of complement activation(GO:0045916) negative regulation of protein activation cascade(GO:2000258) |
0.1 | 0.6 | GO:0001967 | suckling behavior(GO:0001967) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.5 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.1 | 0.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.1 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.2 | GO:0033387 | putrescine biosynthetic process from ornithine(GO:0033387) |
0.1 | 0.1 | GO:0045940 | positive regulation of steroid metabolic process(GO:0045940) |
0.1 | 0.9 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.6 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
0.1 | 0.1 | GO:1901979 | regulation of inward rectifier potassium channel activity(GO:1901979) |
0.0 | 0.2 | GO:2000757 | negative regulation of peptidyl-lysine acetylation(GO:2000757) |
0.0 | 0.1 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.0 | 0.0 | GO:1900409 | positive regulation of cellular response to oxidative stress(GO:1900409) positive regulation of response to oxidative stress(GO:1902884) |
0.0 | 0.1 | GO:0048599 | oocyte development(GO:0048599) |
0.0 | 0.1 | GO:0008089 | anterograde axonal transport(GO:0008089) |
0.0 | 0.1 | GO:0035646 | endosome to melanosome transport(GO:0035646) endosome to pigment granule transport(GO:0043485) pigment granule maturation(GO:0048757) |
0.0 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.0 | 0.1 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.0 | 0.3 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.0 | 0.0 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.0 | 0.8 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.0 | 3.3 | GO:0006633 | fatty acid biosynthetic process(GO:0006633) |
0.0 | 0.1 | GO:1902285 | semaphorin-plexin signaling pathway involved in neuron projection guidance(GO:1902285) semaphorin-plexin signaling pathway involved in axon guidance(GO:1902287) |
0.0 | 0.1 | GO:0060676 | ureteric bud formation(GO:0060676) |
0.0 | 0.0 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
0.0 | 0.3 | GO:0060177 | regulation of angiotensin levels in blood(GO:0002002) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.1 | GO:0009629 | response to gravity(GO:0009629) |
0.0 | 1.0 | GO:0006890 | retrograde vesicle-mediated transport, Golgi to ER(GO:0006890) |
0.0 | 0.2 | GO:0036508 | protein deglycosylation involved in glycoprotein catabolic process(GO:0035977) protein demannosylation(GO:0036507) protein alpha-1,2-demannosylation(GO:0036508) mannose trimming involved in glycoprotein ERAD pathway(GO:1904382) |
0.0 | 0.0 | GO:1902188 | positive regulation of viral release from host cell(GO:1902188) |
0.0 | 0.0 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.0 | 1.4 | GO:0098840 | intraciliary transport(GO:0042073) protein transport along microtubule(GO:0098840) |
0.0 | 0.2 | GO:0051694 | pointed-end actin filament capping(GO:0051694) |
0.0 | 3.3 | GO:0002244 | hematopoietic progenitor cell differentiation(GO:0002244) |
0.0 | 0.1 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
0.0 | 0.1 | GO:0021557 | oculomotor nerve development(GO:0021557) trochlear nerve development(GO:0021558) |
0.0 | 0.1 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.0 | 0.1 | GO:1902071 | regulation of hypoxia-inducible factor-1alpha signaling pathway(GO:1902071) |
0.0 | 0.0 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.0 | 0.4 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.4 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 0.2 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.0 | 1.0 | GO:0007339 | binding of sperm to zona pellucida(GO:0007339) |
0.0 | 1.3 | GO:0003341 | cilium movement(GO:0003341) |
0.0 | 0.0 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.0 | 0.0 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.0 | 0.0 | GO:0060900 | embryonic camera-type eye formation(GO:0060900) |
0.0 | 0.2 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.0 | 0.1 | GO:0060546 | negative regulation of necroptotic process(GO:0060546) |
0.0 | 0.0 | GO:0032714 | negative regulation of interleukin-13 production(GO:0032696) negative regulation of interleukin-5 production(GO:0032714) |
0.0 | 0.3 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.0 | 0.1 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.0 | 0.0 | GO:2000525 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.0 | 0.1 | GO:0045978 | negative regulation of nucleoside metabolic process(GO:0045978) negative regulation of ATP metabolic process(GO:1903579) |
0.0 | 0.2 | GO:0019884 | antigen processing and presentation of exogenous antigen(GO:0019884) |
0.0 | 0.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.5 | GO:0032008 | positive regulation of TOR signaling(GO:0032008) |
0.0 | 0.1 | GO:0046325 | negative regulation of glucose transport(GO:0010829) negative regulation of glucose import(GO:0046325) |
0.0 | 0.1 | GO:0019400 | alditol metabolic process(GO:0019400) |
0.0 | 0.1 | GO:0032642 | regulation of chemokine production(GO:0032642) |
0.0 | 0.0 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.0 | 0.2 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.0 | 1.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.1 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) negative regulation of establishment of protein localization to mitochondrion(GO:1903748) |
0.0 | 0.0 | GO:0034773 | histone H4-K20 trimethylation(GO:0034773) regulation of serine phosphorylation of STAT3 protein(GO:1903261) |
0.0 | 0.1 | GO:0072695 | negative regulation of DNA recombination at telomere(GO:0048239) regulation of DNA recombination at telomere(GO:0072695) |
0.0 | 0.1 | GO:0045144 | meiotic sister chromatid segregation(GO:0045144) meiotic sister chromatid cohesion(GO:0051177) |
0.0 | 0.1 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.0 | 0.1 | GO:0022401 | desensitization of G-protein coupled receptor protein signaling pathway(GO:0002029) negative adaptation of signaling pathway(GO:0022401) |
0.0 | 0.2 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.0 | 0.2 | GO:0019433 | triglyceride catabolic process(GO:0019433) |
0.0 | 0.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.0 | 0.2 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.0 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.0 | 0.0 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.0 | 0.1 | GO:0040033 | negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.0 | 0.1 | GO:0060837 | blood vessel endothelial cell differentiation(GO:0060837) |
0.0 | 0.2 | GO:0006040 | amino sugar metabolic process(GO:0006040) |
0.0 | 0.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
0.0 | 0.0 | GO:0003310 | pancreatic A cell differentiation(GO:0003310) |
0.0 | 0.1 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.0 | 0.1 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.0 | 0.5 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.0 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.0 | 0.2 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.2 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.0 | 0.0 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
0.0 | 0.1 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.0 | GO:0090025 | regulation of monocyte chemotaxis(GO:0090025) |
0.0 | 0.0 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.0 | 0.0 | GO:0045448 | regulation of mitotic cell cycle, embryonic(GO:0009794) mitotic cell cycle, embryonic(GO:0045448) |
0.0 | 0.2 | GO:0060009 | Sertoli cell development(GO:0060009) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
0.0 | 0.1 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.1 | GO:0015808 | L-alanine transport(GO:0015808) |
0.0 | 0.1 | GO:0009182 | purine deoxyribonucleoside diphosphate metabolic process(GO:0009182) dGDP metabolic process(GO:0046066) |
0.0 | 0.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.0 | 0.3 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 6.7 | GO:0008380 | RNA splicing(GO:0008380) |
0.0 | 0.4 | GO:0007129 | synapsis(GO:0007129) |
0.0 | 0.1 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.1 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.1 | GO:2000104 | negative regulation of DNA endoreduplication(GO:0032876) negative regulation of DNA-dependent DNA replication(GO:2000104) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.1 | GO:0051984 | positive regulation of chromosome segregation(GO:0051984) |
0.0 | 0.0 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.0 | 0.1 | GO:1900037 | regulation of cellular response to hypoxia(GO:1900037) |
0.0 | 0.1 | GO:0009249 | protein lipoylation(GO:0009249) |
0.0 | 0.1 | GO:0010155 | regulation of proton transport(GO:0010155) |
0.0 | 0.0 | GO:0048850 | hypophysis morphogenesis(GO:0048850) |
0.0 | 0.1 | GO:0035337 | fatty-acyl-CoA metabolic process(GO:0035337) |
0.0 | 0.1 | GO:0051900 | regulation of mitochondrial depolarization(GO:0051900) |
0.0 | 0.0 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.0 | 0.1 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.0 | 0.0 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
0.0 | 0.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.4 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.0 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.0 | 0.0 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.0 | 0.4 | GO:0070979 | protein K11-linked ubiquitination(GO:0070979) |
0.0 | 0.5 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.0 | 0.6 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.1 | GO:0007143 | female meiotic division(GO:0007143) |
0.0 | 0.1 | GO:0035928 | RNA import into mitochondrion(GO:0035927) rRNA import into mitochondrion(GO:0035928) rRNA transport(GO:0051029) |
0.0 | 0.1 | GO:1902004 | positive regulation of beta-amyloid formation(GO:1902004) positive regulation of amyloid precursor protein catabolic process(GO:1902993) |
0.0 | 0.2 | GO:0061005 | cell differentiation involved in kidney development(GO:0061005) |
0.0 | 0.1 | GO:0034975 | protein folding in endoplasmic reticulum(GO:0034975) |
0.0 | 0.1 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.0 | 0.7 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.0 | 0.3 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
0.0 | 0.0 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.0 | 0.4 | GO:0043631 | mRNA polyadenylation(GO:0006378) RNA polyadenylation(GO:0043631) |
0.0 | 0.4 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.1 | GO:0002347 | response to tumor cell(GO:0002347) |
0.0 | 0.2 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.0 | 0.1 | GO:0015889 | cobalamin transport(GO:0015889) |
0.0 | 0.1 | GO:0046685 | response to arsenic-containing substance(GO:0046685) |
0.0 | 0.0 | GO:0060416 | response to growth hormone(GO:0060416) |
0.0 | 0.4 | GO:0045116 | protein neddylation(GO:0045116) |
0.0 | 0.0 | GO:0035106 | operant conditioning(GO:0035106) |
0.0 | 0.2 | GO:0016926 | protein desumoylation(GO:0016926) |
0.0 | 0.0 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.0 | 0.2 | GO:0016180 | snRNA processing(GO:0016180) |
0.0 | 0.1 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.0 | GO:0009750 | response to fructose(GO:0009750) |
0.0 | 0.4 | GO:0051601 | exocyst localization(GO:0051601) |
0.0 | 0.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.0 | 0.0 | GO:0035283 | central nervous system segmentation(GO:0035283) brain segmentation(GO:0035284) |
0.0 | 0.1 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.0 | 0.0 | GO:0048254 | snoRNA localization(GO:0048254) |
0.0 | 0.0 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.0 | 0.9 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.0 | GO:0010452 | histone H3-K36 methylation(GO:0010452) |
0.0 | 0.0 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
0.0 | 0.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 1.0 | GO:0006310 | DNA recombination(GO:0006310) |
0.0 | 0.0 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.1 | GO:0043174 | nucleoside salvage(GO:0043174) |
0.0 | 0.1 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.0 | 0.0 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.1 | GO:0043922 | negative regulation by host of viral transcription(GO:0043922) |
0.0 | 0.1 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.0 | 0.0 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) negative regulation of growth of symbiont involved in interaction with host(GO:0044146) |
0.0 | 0.1 | GO:0051444 | negative regulation of ligase activity(GO:0051352) negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
0.0 | 0.0 | GO:0044860 | protein localization to plasma membrane raft(GO:0044860) |
0.0 | 0.1 | GO:0006116 | NADH oxidation(GO:0006116) |
0.0 | 0.1 | GO:0060084 | synaptic transmission involved in micturition(GO:0060084) |
0.0 | 0.1 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
0.0 | 0.1 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.0 | 0.1 | GO:0061323 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) cell proliferation involved in heart morphogenesis(GO:0061323) |
0.0 | 0.0 | GO:0019042 | viral latency(GO:0019042) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.5 | GO:0045727 | positive regulation of translation(GO:0045727) |
0.0 | 0.0 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.0 | 29.0 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.0 | 0.0 | GO:0034088 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.0 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.0 | 0.0 | GO:2000561 | CD4-positive, alpha-beta T cell proliferation(GO:0035739) regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000561) negative regulation of CD4-positive, alpha-beta T cell proliferation(GO:2000562) |
0.0 | 0.3 | GO:0044804 | nucleophagy(GO:0044804) |
0.0 | 0.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.0 | 0.1 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.0 | 0.1 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.0 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.0 | GO:0033136 | serine phosphorylation of STAT3 protein(GO:0033136) |
0.0 | 0.0 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.0 | 0.6 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 0.1 | GO:0035751 | regulation of lysosomal lumen pH(GO:0035751) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0002068 | glandular epithelial cell development(GO:0002068) |
0.0 | 0.0 | GO:2000484 | positive regulation of interleukin-8 secretion(GO:2000484) |
0.0 | 0.0 | GO:0060126 | somatotropin secreting cell differentiation(GO:0060126) |
0.0 | 0.1 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.0 | 0.0 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.0 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
0.0 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0042796 | snRNA transcription from RNA polymerase III promoter(GO:0042796) |
0.0 | 0.2 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.0 | 0.4 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
0.0 | 0.1 | GO:0061641 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.0 | 0.1 | GO:0033567 | DNA replication, Okazaki fragment processing(GO:0033567) DNA replication, removal of RNA primer(GO:0043137) |
0.0 | 0.1 | GO:1904353 | regulation of telomere capping(GO:1904353) |
0.0 | 0.0 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.0 | 0.3 | GO:0043392 | negative regulation of DNA binding(GO:0043392) |
0.0 | 0.2 | GO:0035458 | cellular response to interferon-beta(GO:0035458) |
0.0 | 0.0 | GO:1990001 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.0 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.0 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.0 | 0.2 | GO:0042773 | ATP synthesis coupled electron transport(GO:0042773) |
0.0 | 0.8 | GO:0001580 | detection of chemical stimulus involved in sensory perception of bitter taste(GO:0001580) |
0.0 | 0.0 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.0 | 0.0 | GO:0006586 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.0 | 0.0 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.0 | 0.1 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.0 | 0.0 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.0 | 0.1 | GO:0072321 | chaperone-mediated protein transport(GO:0072321) |
0.0 | 0.1 | GO:0006968 | cellular defense response(GO:0006968) |
0.0 | 0.0 | GO:0060337 | type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
0.0 | 0.0 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.0 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.0 | 0.0 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleotide catabolic process(GO:0030811) |
0.0 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.0 | 0.1 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
0.0 | 0.0 | GO:0031498 | chromatin disassembly(GO:0031498) |
0.0 | 0.1 | GO:0014047 | glutamate secretion(GO:0014047) |
0.0 | 0.1 | GO:0007032 | endosome organization(GO:0007032) |
0.0 | 0.0 | GO:0060028 | convergent extension involved in axis elongation(GO:0060028) |
0.0 | 0.0 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.0 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.0 | 0.0 | GO:1902630 | regulation of membrane hyperpolarization(GO:1902630) |
0.0 | 0.1 | GO:0070681 | glutaminyl-tRNAGln biosynthesis via transamidation(GO:0070681) |
0.0 | 0.1 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.0 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.0 | 0.1 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.0 | 0.3 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.0 | 0.0 | GO:0002775 | antimicrobial peptide production(GO:0002775) antibacterial peptide production(GO:0002778) |
0.0 | 0.0 | GO:0033762 | response to glucagon(GO:0033762) |
0.0 | 0.0 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.1 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.0 | 0.0 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.0 | 0.1 | GO:0021591 | ventricular system development(GO:0021591) |
0.0 | 0.1 | GO:0010171 | body morphogenesis(GO:0010171) |
0.0 | 0.2 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.0 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.1 | GO:0061042 | vascular wound healing(GO:0061042) |
0.0 | 0.1 | GO:0046548 | retinal rod cell development(GO:0046548) |
0.0 | 0.1 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
0.0 | 0.0 | GO:0001757 | somite specification(GO:0001757) |
0.0 | 0.0 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.0 | 0.1 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.0 | 0.0 | GO:0030210 | heparin biosynthetic process(GO:0030210) |
0.0 | 0.0 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.0 | 0.7 | GO:0007606 | sensory perception of chemical stimulus(GO:0007606) |
0.0 | 0.1 | GO:0045684 | positive regulation of epidermis development(GO:0045684) |
0.0 | 0.0 | GO:0090141 | positive regulation of mitochondrial fission(GO:0090141) |
0.0 | 0.0 | GO:0032383 | regulation of intracellular lipid transport(GO:0032377) regulation of intracellular sterol transport(GO:0032380) regulation of intracellular cholesterol transport(GO:0032383) |
0.0 | 0.0 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.0 | 0.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.0 | 0.1 | GO:0035428 | hexose transmembrane transport(GO:0035428) |
0.0 | 0.0 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.0 | 0.1 | GO:0006228 | UTP biosynthetic process(GO:0006228) |
0.0 | 0.0 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.0 | 0.1 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.0 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.0 | GO:0097112 | gamma-aminobutyric acid receptor clustering(GO:0097112) |
0.0 | 0.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.0 | 0.0 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.0 | 0.1 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.0 | 0.0 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.0 | 0.1 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.0 | 0.0 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
0.0 | 0.0 | GO:0009113 | purine nucleobase biosynthetic process(GO:0009113) |
0.0 | 0.0 | GO:1901873 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.0 | 0.0 | GO:0043400 | cortisol secretion(GO:0043400) regulation of cortisol secretion(GO:0051462) positive regulation of cortisol secretion(GO:0051464) positive regulation of glucocorticoid secretion(GO:2000851) |
0.0 | 0.0 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.0 | 0.0 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.0 | 0.0 | GO:0034144 | negative regulation of toll-like receptor 4 signaling pathway(GO:0034144) |
0.0 | 0.0 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.0 | 0.1 | GO:0006282 | regulation of DNA repair(GO:0006282) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0071321 | cellular response to cGMP(GO:0071321) |
0.0 | 0.2 | GO:0042446 | hormone biosynthetic process(GO:0042446) |
0.0 | 0.0 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.0 | GO:2000758 | positive regulation of peptidyl-lysine acetylation(GO:2000758) |
0.0 | 0.1 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 0.0 | GO:0048255 | mRNA stabilization(GO:0048255) |
0.0 | 0.0 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) |
0.0 | 0.0 | GO:0031077 | post-embryonic camera-type eye development(GO:0031077) |
0.0 | 0.3 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
0.0 | 0.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.0 | 0.0 | GO:0043278 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.0 | 0.0 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.0 | 0.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 0.1 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.0 | 0.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.0 | 0.0 | GO:0009713 | catechol-containing compound biosynthetic process(GO:0009713) catecholamine biosynthetic process(GO:0042423) |
0.0 | 0.0 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.0 | 0.0 | GO:0046459 | short-chain fatty acid metabolic process(GO:0046459) |
0.0 | 0.0 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:1901387 | positive regulation of voltage-gated calcium channel activity(GO:1901387) |
0.0 | 0.1 | GO:0042407 | cristae formation(GO:0042407) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.0 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:1900101 | regulation of endoplasmic reticulum unfolded protein response(GO:1900101) |
0.0 | 0.0 | GO:0035608 | protein deglutamylation(GO:0035608) |
0.0 | 0.0 | GO:0018023 | peptidyl-lysine trimethylation(GO:0018023) |
0.0 | 0.0 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.0 | 0.0 | GO:2000106 | regulation of leukocyte apoptotic process(GO:2000106) |
0.0 | 0.0 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.0 | 0.0 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.0 | 0.1 | GO:0006081 | cellular aldehyde metabolic process(GO:0006081) |
0.0 | 0.0 | GO:0021570 | rhombomere 4 development(GO:0021570) |
0.0 | 0.0 | GO:0006266 | DNA ligation(GO:0006266) |
0.0 | 0.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.0 | 0.0 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.0 | 0.0 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.0 | 0.0 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.0 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.0 | 0.1 | GO:0032088 | negative regulation of NF-kappaB transcription factor activity(GO:0032088) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.6 | 10.4 | GO:0032437 | cuticular plate(GO:0032437) |
2.1 | 10.3 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
1.8 | 5.3 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
1.5 | 4.5 | GO:0043293 | apoptosome(GO:0043293) |
1.5 | 5.8 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.4 | 7.1 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
1.4 | 11.1 | GO:0031209 | SCAR complex(GO:0031209) |
1.3 | 3.8 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
1.2 | 6.2 | GO:0000235 | astral microtubule(GO:0000235) |
1.1 | 3.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.1 | 10.6 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
1.0 | 3.0 | GO:0046691 | intracellular canaliculus(GO:0046691) |
1.0 | 5.0 | GO:0016461 | unconventional myosin complex(GO:0016461) |
1.0 | 5.8 | GO:0042629 | mast cell granule(GO:0042629) |
1.0 | 2.9 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.9 | 2.8 | GO:0000110 | nucleotide-excision repair factor 1 complex(GO:0000110) |
0.9 | 12.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.9 | 7.8 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.8 | 6.5 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.8 | 3.9 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.8 | 2.3 | GO:0005833 | hemoglobin complex(GO:0005833) |
0.8 | 9.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.2 | GO:0020016 | ciliary pocket(GO:0020016) ciliary pocket membrane(GO:0020018) |
0.7 | 5.1 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.7 | 5.6 | GO:0051286 | cell tip(GO:0051286) |
0.7 | 6.2 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.6 | 2.6 | GO:0042583 | chromaffin granule(GO:0042583) |
0.6 | 19.3 | GO:0001772 | immunological synapse(GO:0001772) |
0.6 | 2.5 | GO:1990130 | Iml1 complex(GO:1990130) |
0.6 | 4.3 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.6 | 2.4 | GO:0070876 | SOSS complex(GO:0070876) |
0.6 | 9.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.6 | 4.8 | GO:0030130 | clathrin coat of trans-Golgi network vesicle(GO:0030130) |
0.6 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.6 | 2.3 | GO:0042825 | TAP complex(GO:0042825) |
0.6 | 4.4 | GO:0020005 | symbiont-containing vacuole membrane(GO:0020005) |
0.5 | 4.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.5 | 3.0 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.4 | 1.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.4 | 14.1 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.4 | 3.0 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.4 | 1.3 | GO:0071203 | WASH complex(GO:0071203) |
0.4 | 2.0 | GO:0032584 | growth cone membrane(GO:0032584) |
0.4 | 1.2 | GO:0097443 | sorting endosome(GO:0097443) |
0.4 | 0.8 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.4 | 2.3 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.4 | 10.3 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
0.4 | 1.9 | GO:0000796 | condensin complex(GO:0000796) |
0.4 | 4.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
0.4 | 3.0 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.4 | 3.0 | GO:0070652 | HAUS complex(GO:0070652) |
0.4 | 2.2 | GO:0032009 | early phagosome(GO:0032009) |
0.4 | 1.1 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.4 | 2.5 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 1.4 | GO:1990316 | ATG1/ULK1 kinase complex(GO:1990316) |
0.3 | 1.4 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.3 | 10.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 1.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.3 | 1.3 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.3 | 1.9 | GO:0036057 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.3 | 1.8 | GO:0002177 | manchette(GO:0002177) |
0.3 | 3.7 | GO:0005652 | nuclear lamina(GO:0005652) |
0.3 | 1.2 | GO:0038201 | TOR complex(GO:0038201) |
0.3 | 5.8 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.3 | 9.4 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 1.5 | GO:0001650 | fibrillar center(GO:0001650) |
0.3 | 3.0 | GO:0031143 | pseudopodium(GO:0031143) |
0.3 | 3.8 | GO:0036038 | MKS complex(GO:0036038) |
0.3 | 3.5 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 6.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.3 | 0.9 | GO:0030915 | Smc5-Smc6 complex(GO:0030915) |
0.3 | 2.3 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.3 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.3 | 1.4 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 2.2 | GO:0045179 | apical cortex(GO:0045179) |
0.3 | 1.1 | GO:0072487 | MSL complex(GO:0072487) |
0.3 | 1.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.3 | 11.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.4 | GO:0097422 | tubular endosome(GO:0097422) |
0.3 | 1.1 | GO:0035339 | SPOTS complex(GO:0035339) |
0.3 | 0.8 | GO:0097413 | Lewy body(GO:0097413) |
0.3 | 2.4 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.3 | 1.3 | GO:0031464 | Cul4A-RING E3 ubiquitin ligase complex(GO:0031464) |
0.3 | 4.3 | GO:0005614 | interstitial matrix(GO:0005614) |
0.3 | 0.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.3 | 0.8 | GO:0043596 | nuclear replication fork(GO:0043596) |
0.3 | 15.5 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.3 | 5.6 | GO:0090544 | BAF-type complex(GO:0090544) |
0.3 | 3.5 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.2 | 0.5 | GO:0033263 | CORVET complex(GO:0033263) |
0.2 | 0.7 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
0.2 | 15.4 | GO:0016605 | PML body(GO:0016605) |
0.2 | 0.7 | GO:0000125 | PCAF complex(GO:0000125) |
0.2 | 0.5 | GO:0000835 | ER ubiquitin ligase complex(GO:0000835) Hrd1p ubiquitin ligase complex(GO:0000836) |
0.2 | 0.7 | GO:0031094 | platelet dense tubular network(GO:0031094) |
0.2 | 0.7 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 1.4 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.2 | 1.7 | GO:0032591 | dendritic spine membrane(GO:0032591) |
0.2 | 0.9 | GO:0098536 | deuterosome(GO:0098536) |
0.2 | 0.7 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
0.2 | 2.3 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.2 | 0.2 | GO:0042824 | MHC class I peptide loading complex(GO:0042824) |
0.2 | 0.9 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.2 | 0.2 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
0.2 | 2.8 | GO:0000145 | exocyst(GO:0000145) |
0.2 | 1.1 | GO:0001739 | sex chromatin(GO:0001739) |
0.2 | 0.6 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.2 | 1.1 | GO:0035032 | phosphatidylinositol 3-kinase complex, class III(GO:0035032) |
0.2 | 1.7 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.2 | 4.6 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.2 | 0.8 | GO:0000322 | storage vacuole(GO:0000322) |
0.2 | 1.0 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 0.8 | GO:0097542 | ciliary tip(GO:0097542) |
0.2 | 1.4 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.2 | 0.6 | GO:0005863 | striated muscle myosin thick filament(GO:0005863) |
0.2 | 8.6 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.2 | 0.8 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 1.6 | GO:0070938 | contractile ring(GO:0070938) |
0.2 | 1.4 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.2 | 1.9 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.2 | 1.9 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.2 | 0.6 | GO:0005828 | kinetochore microtubule(GO:0005828) |
0.2 | 0.8 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.2 | 1.3 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.2 | 7.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.2 | 0.6 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 0.6 | GO:0005745 | m-AAA complex(GO:0005745) |
0.2 | 0.7 | GO:0044233 | ER-mitochondrion membrane contact site(GO:0044233) |
0.2 | 0.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.2 | 9.3 | GO:0005811 | lipid particle(GO:0005811) |
0.2 | 0.9 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.2 | 6.7 | GO:0005776 | autophagosome(GO:0005776) |
0.2 | 0.2 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 10.6 | GO:0005795 | Golgi stack(GO:0005795) |
0.2 | 0.5 | GO:0001651 | dense fibrillar component(GO:0001651) |
0.2 | 0.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 0.3 | GO:0070044 | synaptobrevin 2-SNAP-25-syntaxin-1a complex(GO:0070044) |
0.2 | 0.7 | GO:0032021 | NELF complex(GO:0032021) |
0.2 | 0.7 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.2 | 2.3 | GO:0035869 | ciliary transition zone(GO:0035869) |
0.2 | 1.7 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.2 | 2.2 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.2 | 1.0 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.2 | 0.8 | GO:0031597 | cytosolic proteasome complex(GO:0031597) |
0.2 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.2 | 0.5 | GO:0000811 | GINS complex(GO:0000811) |
0.2 | 2.9 | GO:0034451 | centriolar satellite(GO:0034451) |
0.2 | 0.3 | GO:0009279 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.2 | 9.4 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.2 | 0.2 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 2.8 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.2 | 0.8 | GO:0031595 | nuclear proteasome complex(GO:0031595) |
0.2 | 1.2 | GO:0031011 | Ino80 complex(GO:0031011) |
0.2 | 1.2 | GO:0032300 | mismatch repair complex(GO:0032300) |
0.2 | 0.6 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.1 | 0.7 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.1 | 2.1 | GO:0051233 | spindle midzone(GO:0051233) |
0.1 | 0.4 | GO:0005726 | perichromatin fibrils(GO:0005726) |
0.1 | 0.4 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 0.3 | GO:0044308 | axonal spine(GO:0044308) |
0.1 | 1.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.1 | 1.5 | GO:0044453 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
0.1 | 1.4 | GO:0030914 | STAGA complex(GO:0030914) |
0.1 | 1.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 1.0 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.1 | 0.4 | GO:0031084 | BLOC-2 complex(GO:0031084) |
0.1 | 1.7 | GO:0002102 | podosome(GO:0002102) |
0.1 | 7.8 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 12.7 | GO:0072562 | blood microparticle(GO:0072562) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.1 | 0.3 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.1 | 4.6 | GO:0016592 | mediator complex(GO:0016592) |
0.1 | 1.1 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.1 | 1.9 | GO:0060293 | P granule(GO:0043186) pole plasm(GO:0045495) germ plasm(GO:0060293) |
0.1 | 1.8 | GO:0005779 | integral component of peroxisomal membrane(GO:0005779) |
0.1 | 1.1 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.1 | 0.9 | GO:0071014 | post-mRNA release spliceosomal complex(GO:0071014) |
0.1 | 0.8 | GO:0031931 | TORC1 complex(GO:0031931) |
0.1 | 2.3 | GO:0005605 | basal lamina(GO:0005605) |
0.1 | 46.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.1 | 0.3 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.1 | 1.1 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.1 | 1.3 | GO:0072546 | ER membrane protein complex(GO:0072546) |
0.1 | 1.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.1 | 4.3 | GO:0005684 | U2-type spliceosomal complex(GO:0005684) |
0.1 | 2.7 | GO:0005680 | anaphase-promoting complex(GO:0005680) |
0.1 | 0.4 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.1 | 0.3 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 2.2 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.1 | 15.7 | GO:0031965 | nuclear membrane(GO:0031965) |
0.1 | 1.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.4 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.1 | 1.9 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.1 | 0.2 | GO:0097427 | microtubule bundle(GO:0097427) |
0.1 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.1 | 0.4 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.2 | GO:0016939 | kinesin II complex(GO:0016939) |
0.1 | 0.6 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.6 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) proton-transporting ATP synthase complex, catalytic core F(1)(GO:0045261) |
0.1 | 4.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:0070552 | BRISC complex(GO:0070552) |
0.1 | 0.1 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
0.1 | 0.5 | GO:0043203 | axon hillock(GO:0043203) |
0.1 | 1.1 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.8 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.1 | 1.4 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.1 | 2.9 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 1.0 | GO:0035631 | CD40 receptor complex(GO:0035631) |
0.1 | 0.4 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 0.3 | GO:0042581 | specific granule(GO:0042581) |
0.1 | 0.8 | GO:0000242 | pericentriolar material(GO:0000242) |
0.1 | 0.5 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.1 | GO:0030870 | Mre11 complex(GO:0030870) |
0.1 | 2.2 | GO:0031903 | peroxisomal membrane(GO:0005778) microbody membrane(GO:0031903) |
0.1 | 1.1 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
0.1 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.1 | 0.4 | GO:0031502 | dolichyl-phosphate-mannose-protein mannosyltransferase complex(GO:0031502) |
0.1 | 4.8 | GO:0016363 | nuclear matrix(GO:0016363) |
0.1 | 0.5 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 0.1 | GO:0031264 | death-inducing signaling complex(GO:0031264) |
0.1 | 0.4 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.7 | GO:0000178 | exosome (RNase complex)(GO:0000178) |
0.1 | 0.8 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
0.1 | 0.2 | GO:0000942 | condensed nuclear chromosome outer kinetochore(GO:0000942) |
0.1 | 2.4 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 1.7 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.1 | 0.4 | GO:0031512 | motile primary cilium(GO:0031512) |
0.1 | 0.3 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 2.4 | GO:0000776 | kinetochore(GO:0000776) |
0.1 | 0.2 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.4 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 0.8 | GO:0031430 | M band(GO:0031430) |
0.1 | 0.1 | GO:0000812 | Swr1 complex(GO:0000812) |
0.1 | 0.1 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
0.1 | 1.4 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.1 | 0.1 | GO:0035102 | PRC1 complex(GO:0035102) |
0.1 | 0.3 | GO:0031415 | NatA complex(GO:0031415) |
0.1 | 4.1 | GO:0000502 | proteasome complex(GO:0000502) |
0.1 | 8.8 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.1 | 0.4 | GO:0071953 | elastic fiber(GO:0071953) |
0.1 | 0.7 | GO:0005675 | holo TFIIH complex(GO:0005675) |
0.1 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.1 | 1.8 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.1 | 0.3 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.1 | 6.8 | GO:0000139 | Golgi membrane(GO:0000139) |
0.1 | 0.5 | GO:0097539 | ciliary transition fiber(GO:0097539) |
0.1 | 0.9 | GO:0001527 | microfibril(GO:0001527) |
0.1 | 0.4 | GO:0070775 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.1 | 0.1 | GO:0033269 | internode region of axon(GO:0033269) |
0.1 | 16.1 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.1 | 0.1 | GO:0034363 | intermediate-density lipoprotein particle(GO:0034363) |
0.1 | 3.8 | GO:0005770 | late endosome(GO:0005770) |
0.1 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 4.5 | GO:0005938 | cell cortex(GO:0005938) |
0.1 | 2.3 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.1 | 0.6 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.4 | GO:0036464 | cytoplasmic ribonucleoprotein granule(GO:0036464) |
0.1 | 1.0 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.1 | 19.3 | GO:0005667 | transcription factor complex(GO:0005667) |
0.1 | 0.1 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.1 | 0.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.6 | GO:0034719 | SMN-Sm protein complex(GO:0034719) |
0.1 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.1 | 0.2 | GO:0072687 | meiotic spindle(GO:0072687) |
0.1 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.1 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.1 | 0.3 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 0.6 | GO:0005916 | fascia adherens(GO:0005916) |
0.1 | 2.9 | GO:0030133 | transport vesicle(GO:0030133) |
0.1 | 3.5 | GO:0012506 | vesicle membrane(GO:0012506) |
0.1 | 0.1 | GO:0043656 | host cell cytoplasm(GO:0030430) host intracellular part(GO:0033646) host cell cytoplasm part(GO:0033655) intracellular region of host(GO:0043656) |
0.1 | 1.7 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 0.2 | GO:0031984 | organelle subcompartment(GO:0031984) |
0.1 | 0.6 | GO:0002199 | zona pellucida receptor complex(GO:0002199) |
0.1 | 26.2 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.1 | 0.1 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.6 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 0.4 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.1 | 0.7 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.1 | 2.0 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 5.9 | GO:0016604 | nuclear body(GO:0016604) |
0.1 | 0.4 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.1 | 0.8 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.1 | 51.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.1 | 0.8 | GO:0043073 | male germ cell nucleus(GO:0001673) germ cell nucleus(GO:0043073) |
0.1 | 0.2 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.1 | 2.7 | GO:0000793 | condensed chromosome(GO:0000793) |
0.1 | 0.3 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.1 | 0.3 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 0.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.1 | 0.4 | GO:0043189 | NuA4 histone acetyltransferase complex(GO:0035267) H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 1.4 | GO:0045171 | intercellular bridge(GO:0045171) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.1 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.1 | 0.3 | GO:0070578 | RISC-loading complex(GO:0070578) |
0.1 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.1 | 0.3 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.1 | 1.6 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 53.2 | GO:0005654 | nucleoplasm(GO:0005654) |
0.1 | 0.2 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 0.1 | GO:0034709 | methylosome(GO:0034709) |
0.1 | 0.5 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 1.7 | GO:0010008 | endosome membrane(GO:0010008) |
0.1 | 0.3 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.1 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
0.1 | 0.4 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.1 | 0.2 | GO:0000938 | GARP complex(GO:0000938) |
0.1 | 2.9 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.1 | 27.1 | GO:0005794 | Golgi apparatus(GO:0005794) |
0.1 | 33.6 | GO:0005783 | endoplasmic reticulum(GO:0005783) |
0.1 | 0.2 | GO:0000803 | sex chromosome(GO:0000803) |
0.1 | 0.1 | GO:0031258 | lamellipodium membrane(GO:0031258) |
0.0 | 0.1 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.0 | 0.0 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 1.2 | GO:0016528 | sarcoplasm(GO:0016528) |
0.0 | 1.8 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 0.4 | GO:0036157 | outer dynein arm(GO:0036157) |
0.0 | 0.0 | GO:0044292 | dendrite terminus(GO:0044292) |
0.0 | 0.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.0 | 7.0 | GO:0048471 | perinuclear region of cytoplasm(GO:0048471) |
0.0 | 0.0 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.0 | 0.1 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.7 | GO:0005902 | microvillus(GO:0005902) |
0.0 | 0.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 2.8 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.3 | GO:0032154 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.1 | GO:0045120 | pronucleus(GO:0045120) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.1 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.0 | 0.1 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
0.0 | 0.1 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.0 | 0.1 | GO:0097452 | GAIT complex(GO:0097452) |
0.0 | 0.1 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.0 | 0.3 | GO:0036156 | inner dynein arm(GO:0036156) |
0.0 | 0.1 | GO:0042627 | chylomicron(GO:0042627) |
0.0 | 0.6 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 1.1 | GO:0005769 | early endosome(GO:0005769) |
0.0 | 0.0 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.0 | 1.4 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 4.2 | GO:0005874 | microtubule(GO:0005874) |
0.0 | 1.4 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 1.7 | GO:0015934 | large ribosomal subunit(GO:0015934) |
0.0 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.1 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.2 | GO:0005875 | microtubule associated complex(GO:0005875) |
0.0 | 31.7 | GO:0070062 | extracellular exosome(GO:0070062) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.0 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
0.0 | 0.1 | GO:0097648 | G-protein coupled receptor dimeric complex(GO:0038037) G-protein coupled receptor complex(GO:0097648) |
0.0 | 0.0 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
0.0 | 2.3 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.1 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.0 | 0.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 0.1 | GO:0060091 | kinocilium(GO:0060091) |
0.0 | 0.0 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.2 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 0.1 | GO:0089717 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.0 | 0.0 | GO:0030056 | hemidesmosome(GO:0030056) |
0.0 | 1.0 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.0 | 0.0 | GO:0000439 | core TFIIH complex(GO:0000439) |
0.0 | 10.4 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.0 | 0.1 | GO:0043218 | compact myelin(GO:0043218) |
0.0 | 0.0 | GO:0030894 | replisome(GO:0030894) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.0 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.0 | GO:0097342 | ripoptosome(GO:0097342) |
0.0 | 0.2 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.0 | GO:0061702 | inflammasome complex(GO:0061702) |
0.0 | 0.0 | GO:0034464 | BBSome(GO:0034464) |
0.0 | 0.0 | GO:0044447 | axoneme part(GO:0044447) |
0.0 | 0.0 | GO:0042555 | MCM complex(GO:0042555) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 12.8 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
3.1 | 12.5 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
2.6 | 10.4 | GO:0042731 | PH domain binding(GO:0042731) |
2.2 | 10.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
2.1 | 12.3 | GO:0032184 | SUMO polymer binding(GO:0032184) |
2.0 | 5.9 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
1.8 | 1.8 | GO:0018423 | protein C-terminal leucine carboxyl O-methyltransferase activity(GO:0018423) |
1.7 | 6.6 | GO:0051425 | PTB domain binding(GO:0051425) |
1.5 | 4.6 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
1.5 | 5.9 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
1.4 | 2.9 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.4 | 5.7 | GO:0030911 | TPR domain binding(GO:0030911) |
1.4 | 8.4 | GO:0008559 | xenobiotic-transporting ATPase activity(GO:0008559) |
1.4 | 4.1 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
1.3 | 6.5 | GO:0015189 | arginine transmembrane transporter activity(GO:0015181) L-lysine transmembrane transporter activity(GO:0015189) |
1.3 | 3.9 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
1.3 | 5.1 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
1.3 | 2.5 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
1.2 | 3.7 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
1.2 | 4.9 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.2 | 6.0 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
1.2 | 4.8 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.2 | 6.0 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.1 | 3.2 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
1.0 | 5.2 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
1.0 | 8.2 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
1.0 | 6.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
1.0 | 3.8 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.9 | 2.7 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.9 | 6.2 | GO:0046790 | virion binding(GO:0046790) |
0.9 | 7.9 | GO:0032183 | SUMO binding(GO:0032183) |
0.9 | 3.5 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.9 | 2.6 | GO:0043199 | sulfate binding(GO:0043199) |
0.8 | 10.0 | GO:0051400 | BH domain binding(GO:0051400) |
0.8 | 4.0 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.8 | 4.0 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
0.8 | 4.0 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.8 | 3.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.8 | 3.1 | GO:0030984 | kininogen binding(GO:0030984) |
0.8 | 2.3 | GO:0046979 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
0.8 | 3.1 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.8 | 2.3 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.8 | 3.8 | GO:0004523 | RNA-DNA hybrid ribonuclease activity(GO:0004523) |
0.7 | 4.5 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.7 | 2.2 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
0.7 | 3.6 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.7 | 13.4 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.7 | 9.2 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.7 | 11.9 | GO:0009931 | calcium-dependent protein serine/threonine kinase activity(GO:0009931) |
0.7 | 6.3 | GO:0097153 | cysteine-type endopeptidase activity involved in apoptotic process(GO:0097153) |
0.7 | 2.8 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
0.7 | 3.5 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.7 | 1.4 | GO:0008379 | thioredoxin peroxidase activity(GO:0008379) |
0.7 | 1.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
0.7 | 2.0 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
0.7 | 2.0 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.7 | 4.6 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.7 | 6.5 | GO:0015168 | glycerol transmembrane transporter activity(GO:0015168) glycerol channel activity(GO:0015254) |
0.6 | 1.9 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.6 | 1.9 | GO:0004477 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.6 | 2.5 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.6 | 4.3 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) |
0.6 | 8.5 | GO:0005542 | folic acid binding(GO:0005542) |
0.6 | 1.8 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.6 | 3.6 | GO:0005168 | neurotrophin TRKA receptor binding(GO:0005168) |
0.6 | 1.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.6 | 3.5 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.6 | 1.7 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
0.6 | 1.7 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.5 | 6.5 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.5 | 10.3 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.5 | 5.4 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.5 | 14.7 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
0.5 | 2.5 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.5 | 2.5 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.5 | 1.5 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.5 | 7.8 | GO:0008143 | poly(A) binding(GO:0008143) |
0.5 | 3.9 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.5 | 4.3 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.5 | 5.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.5 | 1.9 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.5 | 2.3 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.5 | 2.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.5 | 1.8 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.5 | 2.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.5 | 1.8 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.5 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.5 | 1.8 | GO:0004370 | glycerol kinase activity(GO:0004370) |
0.5 | 1.8 | GO:0004558 | alpha-1,4-glucosidase activity(GO:0004558) |
0.5 | 1.4 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.5 | 2.3 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.4 | 3.5 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.4 | 1.3 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.4 | 3.4 | GO:1990381 | ubiquitin-specific protease binding(GO:1990381) |
0.4 | 1.3 | GO:0032137 | guanine/thymine mispair binding(GO:0032137) |
0.4 | 0.8 | GO:0019808 | polyamine binding(GO:0019808) |
0.4 | 4.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.4 | 6.7 | GO:0008187 | poly-pyrimidine tract binding(GO:0008187) |
0.4 | 0.4 | GO:0000403 | Y-form DNA binding(GO:0000403) |
0.4 | 0.8 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
0.4 | 1.7 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.4 | 1.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.4 | 1.7 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.4 | 2.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.4 | 0.8 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.4 | 13.5 | GO:0004712 | protein serine/threonine/tyrosine kinase activity(GO:0004712) |
0.4 | 1.6 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.4 | 5.9 | GO:0019825 | oxygen binding(GO:0019825) |
0.4 | 2.0 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.4 | 3.5 | GO:0031386 | protein tag(GO:0031386) |
0.4 | 2.4 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.4 | 1.2 | GO:0004619 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.4 | 1.5 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
0.4 | 3.4 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.4 | 1.5 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.4 | 1.5 | GO:0004046 | aminoacylase activity(GO:0004046) |
0.4 | 0.8 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.4 | 0.4 | GO:0050543 | icosatetraenoic acid binding(GO:0050543) |
0.4 | 1.9 | GO:0070513 | death domain binding(GO:0070513) |
0.4 | 1.5 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
0.4 | 3.7 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.4 | 1.5 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 3.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.4 | 2.5 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.4 | 3.6 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.4 | 1.8 | GO:0071253 | connexin binding(GO:0071253) |
0.4 | 1.4 | GO:0043559 | insulin binding(GO:0043559) |
0.4 | 2.5 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.4 | 1.1 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.4 | 1.1 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) |
0.4 | 7.8 | GO:0030332 | cyclin binding(GO:0030332) |
0.4 | 6.0 | GO:0005112 | Notch binding(GO:0005112) |
0.4 | 6.3 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.4 | 3.9 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
0.4 | 1.4 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.3 | 2.8 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.3 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 3.1 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 1.7 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
0.3 | 1.7 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.3 | 1.0 | GO:0031826 | type 2A serotonin receptor binding(GO:0031826) |
0.3 | 0.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 1.0 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 1.0 | GO:0019961 | interferon binding(GO:0019961) |
0.3 | 1.0 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.3 | 2.2 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
0.3 | 1.9 | GO:0035173 | histone kinase activity(GO:0035173) |
0.3 | 0.6 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.3 | 8.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.3 | 1.8 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.3 | 0.9 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.3 | 1.2 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.3 | 1.5 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.3 | 5.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.3 | 16.7 | GO:0019209 | kinase activator activity(GO:0019209) |
0.3 | 2.7 | GO:0042500 | aspartic endopeptidase activity, intramembrane cleaving(GO:0042500) |
0.3 | 7.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.3 | 1.5 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.3 | 1.5 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.3 | 2.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
0.3 | 1.2 | GO:0005346 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine ribonucleotide transmembrane transporter activity(GO:0005346) purine nucleotide transmembrane transporter activity(GO:0015216) |
0.3 | 2.4 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
0.3 | 0.9 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.3 | 2.1 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
0.3 | 2.4 | GO:1990405 | protein antigen binding(GO:1990405) |
0.3 | 2.4 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.3 | 0.9 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.3 | 1.5 | GO:0017040 | ceramidase activity(GO:0017040) |
0.3 | 11.7 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.3 | 12.8 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.3 | 2.5 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.3 | 3.6 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
0.3 | 1.1 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.3 | 1.7 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.3 | 14.2 | GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding(GO:0000979) |
0.3 | 1.9 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.3 | 0.8 | GO:0004104 | cholinesterase activity(GO:0004104) |
0.3 | 0.3 | GO:0050692 | DBD domain binding(GO:0050692) |
0.3 | 0.3 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
0.3 | 1.6 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.3 | 0.8 | GO:0004802 | transketolase activity(GO:0004802) |
0.3 | 1.3 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
0.3 | 0.8 | GO:0052813 | phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.3 | 1.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.3 | 0.3 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.3 | 9.7 | GO:0001046 | core promoter sequence-specific DNA binding(GO:0001046) |
0.3 | 1.8 | GO:0035197 | siRNA binding(GO:0035197) |
0.3 | 1.3 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.3 | 1.0 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.3 | 1.0 | GO:0030572 | cardiolipin synthase activity(GO:0008808) phosphatidyltransferase activity(GO:0030572) |
0.3 | 0.8 | GO:0015232 | heme transporter activity(GO:0015232) |
0.3 | 0.3 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.3 | 1.0 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.3 | 9.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.3 | 2.3 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
0.3 | 2.3 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.3 | 1.8 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.3 | 0.3 | GO:0016273 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.2 | 3.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.2 | 0.7 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 2.2 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.2 | 1.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.2 | 3.1 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.2 | 2.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.9 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
0.2 | 0.7 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
0.2 | 0.7 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.2 | 2.6 | GO:0015278 | calcium-release channel activity(GO:0015278) ligand-gated calcium channel activity(GO:0099604) |
0.2 | 2.6 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.2 | 0.7 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
0.2 | 0.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.2 | 2.1 | GO:0016215 | acyl-CoA desaturase activity(GO:0016215) |
0.2 | 9.9 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.2 | 0.7 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.2 | 1.1 | GO:0008199 | ferric iron binding(GO:0008199) |
0.2 | 0.5 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.2 | 2.3 | GO:0043422 | protein kinase B binding(GO:0043422) |
0.2 | 0.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.2 | 1.6 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 1.3 | GO:0002054 | nucleobase binding(GO:0002054) |
0.2 | 0.7 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.2 | 1.5 | GO:0016004 | phospholipase activator activity(GO:0016004) |
0.2 | 1.1 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.2 | 1.1 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 0.7 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.7 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.2 | 6.5 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.2 | 42.1 | GO:0070737 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.2 | 6.7 | GO:0043908 | prenylcysteine methylesterase activity(GO:0010296) 1-oxa-2-oxocycloheptane lactonase activity(GO:0018731) sulfolactone hydrolase activity(GO:0018732) butyrolactone hydrolase activity(GO:0018734) endosulfan lactone lactonase activity(GO:0034892) L-ascorbate 6-phosphate lactonase activity(GO:0035460) Ser-tRNA(Thr) hydrolase activity(GO:0043905) Ala-tRNA(Pro) hydrolase activity(GO:0043906) Cys-tRNA(Pro) hydrolase activity(GO:0043907) Ser(Gly)-tRNA(Ala) hydrolase activity(GO:0043908) all-trans-retinyl-palmitate hydrolase, all-trans-retinol forming activity(GO:0047376) mannosyl-oligosaccharide 1,6-alpha-mannosidase activity(GO:0052767) mannosyl-oligosaccharide 1,3-alpha-mannosidase activity(GO:0052768) methyl indole-3-acetate esterase activity(GO:0080030) methyl salicylate esterase activity(GO:0080031) methyl jasmonate esterase activity(GO:0080032) |
0.2 | 0.6 | GO:0052658 | inositol-1,4,5-trisphosphate 5-phosphatase activity(GO:0052658) |
0.2 | 0.4 | GO:0043842 | Kdo transferase activity(GO:0043842) |
0.2 | 0.6 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.2 | 3.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.2 | 4.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.2 | 0.4 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.2 | 1.0 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.2 | 0.6 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.2 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.2 | 0.2 | GO:0018733 | 3,4-dihydrocoumarin hydrolase activity(GO:0018733) |
0.2 | 0.4 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 2.8 | GO:0018024 | histone-lysine N-methyltransferase activity(GO:0018024) |
0.2 | 18.1 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 1.2 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.2 | 4.2 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.2 | 0.6 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.2 | 0.6 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.2 | 1.2 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
0.2 | 0.8 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.2 | 1.7 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.9 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.2 | 2.3 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.2 | 1.0 | GO:0052723 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) inositol hexakisphosphate 1-kinase activity(GO:0052723) inositol hexakisphosphate 3-kinase activity(GO:0052724) |
0.2 | 0.6 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.2 | 0.8 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.2 | 1.1 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 2.5 | GO:0005521 | lamin binding(GO:0005521) |
0.2 | 2.5 | GO:0010181 | FMN binding(GO:0010181) |
0.2 | 2.3 | GO:0070402 | NADPH binding(GO:0070402) |
0.2 | 0.8 | GO:0032052 | bile acid binding(GO:0032052) |
0.2 | 0.6 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.2 | 0.6 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.2 | 0.6 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.2 | 1.7 | GO:0034847 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.2 | 2.0 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.2 | 0.6 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
0.2 | 1.7 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.2 | 0.9 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.2 | 0.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.9 | GO:0030955 | potassium ion binding(GO:0030955) |
0.2 | 0.5 | GO:0034452 | dynactin binding(GO:0034452) |
0.2 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.2 | 0.4 | GO:0035276 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) ethanol binding(GO:0035276) |
0.2 | 0.5 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.2 | 1.6 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.2 | 0.9 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.2 | 0.3 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.2 | 3.1 | GO:0015145 | monosaccharide transmembrane transporter activity(GO:0015145) hexose transmembrane transporter activity(GO:0015149) |
0.2 | 0.3 | GO:0051373 | FATZ binding(GO:0051373) |
0.2 | 0.3 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 4.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.2 | 0.5 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.2 | 2.4 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.2 | 3.5 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.2 | 0.3 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.2 | 0.5 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.2 | 0.5 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.2 | 1.3 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
0.2 | 0.7 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.2 | 2.7 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.2 | 3.1 | GO:0005086 | ARF guanyl-nucleotide exchange factor activity(GO:0005086) |
0.2 | 0.3 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.2 | 0.5 | GO:0030621 | U4 snRNA binding(GO:0030621) |
0.2 | 0.8 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 0.5 | GO:0004416 | hydroxyacylglutathione hydrolase activity(GO:0004416) |
0.2 | 0.6 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.2 | 1.6 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.2 | 0.6 | GO:0003680 | AT DNA binding(GO:0003680) |
0.2 | 0.8 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.2 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.2 | 0.8 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.2 | 0.3 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.2 | 4.4 | GO:0043826 | N-ethylmaleimide reductase activity(GO:0008748) reduced coenzyme F420 dehydrogenase activity(GO:0043738) sulfur oxygenase reductase activity(GO:0043826) malolactic enzyme activity(GO:0043883) NADPH:sulfur oxidoreductase activity(GO:0043914) epoxyqueuosine reductase activity(GO:0052693) |
0.2 | 0.3 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.2 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.2 | 0.6 | GO:1990932 | 5.8S rRNA binding(GO:1990932) |
0.2 | 1.1 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
0.2 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.2 | 2.6 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.7 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.1 | 1.5 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
0.1 | 0.4 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.7 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.1 | 2.4 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.1 | 3.2 | GO:0016849 | phosphorus-oxygen lyase activity(GO:0016849) |
0.1 | 1.5 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.1 | 0.6 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.1 | 0.4 | GO:0000386 | second spliceosomal transesterification activity(GO:0000386) |
0.1 | 0.3 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.1 | 0.4 | GO:0017089 | glycolipid transporter activity(GO:0017089) |
0.1 | 0.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.6 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.1 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 0.4 | GO:0070052 | collagen V binding(GO:0070052) |
0.1 | 0.7 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.1 | 0.4 | GO:0015211 | purine nucleoside transmembrane transporter activity(GO:0015211) |
0.1 | 2.1 | GO:0043175 | RNA polymerase core enzyme binding(GO:0043175) |
0.1 | 0.3 | GO:0031726 | CCR1 chemokine receptor binding(GO:0031726) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.7 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.7 | GO:0070034 | telomerase RNA binding(GO:0070034) |
0.1 | 0.3 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.1 | 1.9 | GO:0003924 | GTPase activity(GO:0003924) |
0.1 | 0.5 | GO:0032557 | pyrimidine ribonucleotide binding(GO:0032557) |
0.1 | 0.1 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 0.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 1.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.1 | 9.4 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.5 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.4 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.1 | 5.8 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.1 | GO:0016414 | O-octanoyltransferase activity(GO:0016414) |
0.1 | 8.0 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.1 | 0.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.1 | 2.7 | GO:0045502 | dynein binding(GO:0045502) |
0.1 | 0.5 | GO:0009374 | biotin binding(GO:0009374) |
0.1 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.1 | 1.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 0.6 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.9 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.1 | 0.4 | GO:0016971 | flavin-linked sulfhydryl oxidase activity(GO:0016971) |
0.1 | 0.4 | GO:0047105 | aminobutyraldehyde dehydrogenase activity(GO:0019145) 4-trimethylammoniobutyraldehyde dehydrogenase activity(GO:0047105) |
0.1 | 0.2 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.1 | 1.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.1 | 1.0 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.2 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.1 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.1 | 0.9 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
0.1 | 0.6 | GO:0043996 | histone acetyltransferase activity (H4-K5 specific)(GO:0043995) histone acetyltransferase activity (H4-K8 specific)(GO:0043996) histone acetyltransferase activity (H4-K16 specific)(GO:0046972) |
0.1 | 0.4 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.1 | 2.2 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 0.7 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.8 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
0.1 | 2.0 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.7 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.1 | 0.6 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.1 | 0.2 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.2 | GO:0098505 | G-rich strand telomeric DNA binding(GO:0098505) |
0.1 | 0.7 | GO:0034784 | pivalyl-CoA mutase activity(GO:0034784) o-hydroxylaminobenzoate mutase activity(GO:0034951) lupeol synthase activity(GO:0042299) beta-amyrin synthase activity(GO:0042300) baruol synthase activity(GO:0080011) |
0.1 | 0.3 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.1 | 1.5 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
0.1 | 0.4 | GO:0086006 | voltage-gated sodium channel activity involved in cardiac muscle cell action potential(GO:0086006) |
0.1 | 0.3 | GO:0005483 | soluble NSF attachment protein activity(GO:0005483) |
0.1 | 0.3 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.1 | 0.2 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.1 | 1.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.1 | 1.7 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.4 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.3 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.1 | 0.6 | GO:0032795 | heterotrimeric G-protein binding(GO:0032795) |
0.1 | 0.3 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.1 | 1.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.1 | 0.3 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.1 | 0.3 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.1 | 0.7 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 2.2 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.3 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.1 | 0.5 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.1 | 2.1 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
0.1 | 0.7 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.1 | 0.2 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.1 | 0.1 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.1 | 0.4 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.1 | 0.2 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
0.1 | 0.1 | GO:0051723 | protein methylesterase activity(GO:0051723) |
0.1 | 1.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 2.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.2 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
0.1 | 0.3 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.1 | 0.8 | GO:0019843 | rRNA binding(GO:0019843) |
0.1 | 0.7 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.1 | 0.6 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
0.1 | 0.6 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.2 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.1 | 0.2 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.1 | 0.8 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.1 | 7.0 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.1 | 0.5 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.1 | 0.5 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.1 | 0.2 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
0.1 | 0.3 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.3 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.1 | 0.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.1 | 0.6 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 1.2 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.3 | GO:0001075 | transcription factor activity, RNA polymerase II core promoter sequence-specific binding involved in preinitiation complex assembly(GO:0001075) |
0.1 | 7.7 | GO:0017137 | Rab GTPase binding(GO:0017137) |
0.1 | 1.4 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.1 | 0.3 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.5 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 1.4 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.1 | 2.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.1 | 1.4 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.1 | 0.4 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.1 | 0.3 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
0.1 | 1.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 0.4 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.5 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.1 | 2.8 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.1 | 0.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 0.3 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.1 | 0.7 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 0.5 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.1 | 0.5 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 6.3 | GO:0061659 | ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.8 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.1 | 1.0 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.1 | 0.9 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.3 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.1 | 0.7 | GO:0005048 | signal sequence binding(GO:0005048) |
0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 0.4 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.1 | 1.1 | GO:0016594 | glycine binding(GO:0016594) |
0.1 | 0.2 | GO:0031014 | troponin T binding(GO:0031014) |
0.1 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
0.1 | 0.6 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.1 | 0.5 | GO:0015643 | toxic substance binding(GO:0015643) |
0.1 | 0.1 | GO:0070728 | leucine binding(GO:0070728) |
0.1 | 0.4 | GO:0000339 | RNA cap binding(GO:0000339) |
0.1 | 0.7 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.1 | 2.1 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 1.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.1 | 0.2 | GO:0031433 | telethonin binding(GO:0031433) |
0.1 | 0.5 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 0.3 | GO:0015106 | bicarbonate transmembrane transporter activity(GO:0015106) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 1.6 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.1 | 0.1 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 1.0 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.1 | 1.9 | GO:0005184 | neuropeptide hormone activity(GO:0005184) |
0.1 | 0.7 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.1 | 0.2 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.1 | 0.4 | GO:0004169 | dolichyl-phosphate-mannose-protein mannosyltransferase activity(GO:0004169) |
0.1 | 0.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.1 | 0.5 | GO:0005227 | calcium activated cation channel activity(GO:0005227) |
0.1 | 0.6 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.3 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.1 | 0.1 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.1 | 0.3 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.1 | 2.3 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 5.9 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.1 | 0.8 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.1 | 0.2 | GO:0016892 | endoribonuclease activity, producing 3'-phosphomonoesters(GO:0016892) |
0.1 | 0.3 | GO:0047035 | testosterone dehydrogenase (NAD+) activity(GO:0047035) |
0.1 | 0.5 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.1 | 0.1 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 0.1 | GO:0034618 | arginine binding(GO:0034618) |
0.1 | 0.5 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.1 | 0.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.1 | 0.3 | GO:0003846 | 2-acylglycerol O-acyltransferase activity(GO:0003846) |
0.1 | 0.1 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.4 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.1 | 0.1 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.1 | 0.2 | GO:0071949 | FAD binding(GO:0071949) |
0.1 | 0.2 | GO:0016801 | hydrolase activity, acting on ether bonds(GO:0016801) |
0.1 | 0.1 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.1 | 0.2 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 2.4 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.2 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.2 | GO:0070569 | uridylyltransferase activity(GO:0070569) |
0.1 | 1.8 | GO:0003755 | peptidyl-prolyl cis-trans isomerase activity(GO:0003755) |
0.1 | 1.2 | GO:0001190 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.1 | 1.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.2 | GO:0015180 | L-alanine transmembrane transporter activity(GO:0015180) alanine transmembrane transporter activity(GO:0022858) |
0.1 | 0.4 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.1 | 0.2 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.1 | 0.2 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.1 | 0.6 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.1 | 0.7 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.1 | 0.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 4.3 | GO:0003713 | transcription coactivator activity(GO:0003713) |
0.1 | 0.1 | GO:0070061 | fructose binding(GO:0070061) |
0.1 | 0.2 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.2 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.1 | 0.3 | GO:0047760 | butyrate-CoA ligase activity(GO:0047760) |
0.1 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.1 | 0.8 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.1 | 0.1 | GO:0045340 | mercury ion binding(GO:0045340) |
0.1 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.1 | 0.5 | GO:0031210 | phosphatidylcholine binding(GO:0031210) |
0.1 | 1.3 | GO:0043021 | ribonucleoprotein complex binding(GO:0043021) |
0.1 | 0.2 | GO:0015299 | solute:proton antiporter activity(GO:0015299) |
0.1 | 0.2 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 2.0 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.1 | 0.4 | GO:0016868 | intramolecular transferase activity, phosphotransferases(GO:0016868) |
0.1 | 0.4 | GO:0003796 | lysozyme activity(GO:0003796) |
0.1 | 0.2 | GO:0005280 | hydrogen:amino acid symporter activity(GO:0005280) |
0.1 | 12.8 | GO:0005525 | GTP binding(GO:0005525) |
0.1 | 0.2 | GO:0051861 | glycolipid binding(GO:0051861) |
0.1 | 2.5 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 5.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.1 | 0.1 | GO:0015928 | fucosidase activity(GO:0015928) |
0.1 | 1.0 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.1 | 0.3 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 1.0 | GO:0051219 | phosphoprotein binding(GO:0051219) |
0.1 | 0.1 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.1 | 0.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.2 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.1 | 0.3 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.1 | 0.3 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
0.1 | 0.2 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.1 | 1.2 | GO:0052770 | coenzyme F390-A hydrolase activity(GO:0052770) coenzyme F390-G hydrolase activity(GO:0052771) |
0.1 | 0.2 | GO:0019863 | IgE binding(GO:0019863) |
0.1 | 1.2 | GO:0008009 | chemokine activity(GO:0008009) |
0.0 | 0.4 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.0 | 0.1 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.0 | 0.1 | GO:0050897 | cobalt ion binding(GO:0050897) |
0.0 | 0.2 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
0.0 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.0 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.0 | 0.2 | GO:0031419 | cobalamin binding(GO:0031419) |
0.0 | 0.0 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
0.0 | 0.1 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.2 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.0 | 0.3 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.1 | GO:0004741 | [pyruvate dehydrogenase (lipoamide)] phosphatase activity(GO:0004741) |
0.0 | 0.2 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.0 | 0.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.0 | 0.2 | GO:0010853 | cyclase activator activity(GO:0010853) guanylate cyclase activator activity(GO:0030250) |
0.0 | 8.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.0 | 0.1 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.0 | 1.0 | GO:0051287 | NAD binding(GO:0051287) |
0.0 | 0.1 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.0 | 0.1 | GO:0036435 | K48-linked polyubiquitin binding(GO:0036435) |
0.0 | 0.8 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.4 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.0 | 0.2 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.7 | GO:0015926 | glucosidase activity(GO:0015926) |
0.0 | 1.6 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.5 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 3.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.5 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.0 | 0.2 | GO:0008430 | selenium binding(GO:0008430) |
0.0 | 0.3 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.2 | GO:0033691 | sialic acid binding(GO:0033691) |
0.0 | 0.0 | GO:0030792 | methylarsonite methyltransferase activity(GO:0030792) |
0.0 | 0.0 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.0 | 0.0 | GO:0023023 | MHC protein complex binding(GO:0023023) |
0.0 | 0.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.0 | 0.2 | GO:0017069 | snRNA binding(GO:0017069) |
0.0 | 0.4 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
0.0 | 0.3 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.0 | 0.3 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.0 | 0.6 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.4 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.0 | 0.2 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.0 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.3 | GO:0001158 | enhancer sequence-specific DNA binding(GO:0001158) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 1.2 | GO:0016860 | intramolecular oxidoreductase activity(GO:0016860) |
0.0 | 0.1 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.0 | 0.1 | GO:0005402 | sugar:proton symporter activity(GO:0005351) cation:sugar symporter activity(GO:0005402) |
0.0 | 0.2 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.0 | 0.1 | GO:0000182 | rDNA binding(GO:0000182) |
0.0 | 0.1 | GO:0010858 | calcium-dependent protein kinase regulator activity(GO:0010858) |
0.0 | 0.1 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.0 | 0.1 | GO:0050733 | RS domain binding(GO:0050733) |
0.0 | 0.0 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0004735 | pyrroline-5-carboxylate reductase activity(GO:0004735) |
0.0 | 0.0 | GO:0060229 | lipase activator activity(GO:0060229) |
0.0 | 0.1 | GO:0070840 | dynein complex binding(GO:0070840) |
0.0 | 0.0 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.6 | GO:0016684 | oxidoreductase activity, acting on peroxide as acceptor(GO:0016684) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.5 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.0 | 0.1 | GO:0004359 | glutaminase activity(GO:0004359) |
0.0 | 0.0 | GO:0008061 | chitin binding(GO:0008061) |
0.0 | 0.8 | GO:0016853 | isomerase activity(GO:0016853) |
0.0 | 0.0 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
0.0 | 1.1 | GO:0043765 | integrase activity(GO:0008907) T/G mismatch-specific endonuclease activity(GO:0043765) retroviral integrase activity(GO:0044823) retroviral 3' processing activity(GO:0044824) |
0.0 | 0.2 | GO:0032182 | ubiquitin-like protein binding(GO:0032182) |
0.0 | 0.1 | GO:0031432 | titin binding(GO:0031432) |
0.0 | 0.1 | GO:0016894 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) endonuclease activity, active with either ribo- or deoxyribonucleic acids and producing 3'-phosphomonoesters(GO:0016894) |
0.0 | 0.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.0 | 0.2 | GO:0000150 | recombinase activity(GO:0000150) |
0.0 | 0.0 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.0 | 0.1 | GO:0070697 | activin receptor binding(GO:0070697) |
0.0 | 0.1 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.0 | 0.1 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 3.3 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.0 | 0.0 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.0 | 0.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 31.3 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.3 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.1 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.0 | 0.4 | GO:0005537 | mannose binding(GO:0005537) |
0.0 | 0.1 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.0 | GO:1904680 | oligopeptide transmembrane transporter activity(GO:0035673) peptide transmembrane transporter activity(GO:1904680) |
0.0 | 0.1 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.7 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) |
0.0 | 0.1 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.0 | 0.0 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.0 | 0.1 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.0 | 0.0 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.0 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.0 | 3.5 | GO:0030246 | carbohydrate binding(GO:0030246) |
0.0 | 0.1 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.0 | 0.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0008251 | tRNA-specific adenosine deaminase activity(GO:0008251) |
0.0 | 0.4 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0045545 | syndecan binding(GO:0045545) |
0.0 | 0.1 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.0 | 1.3 | GO:0000149 | SNARE binding(GO:0000149) |
0.0 | 0.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.0 | 0.1 | GO:0052796 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
0.0 | 0.4 | GO:0016229 | steroid dehydrogenase activity(GO:0016229) |
0.0 | 0.4 | GO:0015631 | tubulin binding(GO:0015631) |
0.0 | 0.0 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.0 | 0.3 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.0 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.0 | 0.0 | GO:0052866 | phosphatidylinositol phosphate phosphatase activity(GO:0052866) |
0.0 | 0.0 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.0 | 0.2 | GO:0019215 | intermediate filament binding(GO:0019215) |
0.0 | 0.1 | GO:0031779 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.0 | 0.0 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.0 | 0.6 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.0 | 0.0 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.0 | 0.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.0 | 0.0 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.1 | GO:0015194 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
0.0 | 0.1 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) peptidoglycan receptor activity(GO:0016019) |
0.0 | 0.1 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.8 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.0 | 0.0 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
0.0 | 0.0 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.0 | 0.1 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.0 | 0.1 | GO:0005499 | vitamin D binding(GO:0005499) |
0.0 | 0.2 | GO:0016701 | oxidoreductase activity, acting on single donors with incorporation of molecular oxygen(GO:0016701) |
0.0 | 0.9 | GO:0016820 | hydrolase activity, acting on acid anhydrides, catalyzing transmembrane movement of substances(GO:0016820) |
0.0 | 0.1 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.0 | 0.4 | GO:0030523 | dihydrolipoamide S-acyltransferase activity(GO:0030523) |
0.0 | 0.5 | GO:0035064 | methylated histone binding(GO:0035064) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.1 | GO:0015377 | cation:chloride symporter activity(GO:0015377) |
0.0 | 0.1 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0052745 | inositol phosphate phosphatase activity(GO:0052745) |
0.0 | 0.1 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.0 | 0.0 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.0 | 0.0 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.0 | 0.6 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.0 | GO:0016427 | tRNA (cytosine) methyltransferase activity(GO:0016427) tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.2 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.0 | 0.2 | GO:0001594 | trace-amine receptor activity(GO:0001594) |
0.0 | 0.0 | GO:0098519 | nucleotide phosphatase activity, acting on free nucleotides(GO:0098519) |
0.0 | 2.6 | GO:0017171 | serine hydrolase activity(GO:0017171) |
0.0 | 0.0 | GO:0004862 | cAMP-dependent protein kinase inhibitor activity(GO:0004862) |
0.0 | 0.0 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.0 | 0.1 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 0.0 | GO:0004724 | magnesium-dependent protein serine/threonine phosphatase activity(GO:0004724) |
0.0 | 0.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.3 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.0 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.0 | 0.0 | GO:0004771 | sterol esterase activity(GO:0004771) |
0.0 | 0.0 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.0 | 0.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.9 | GO:0005085 | guanyl-nucleotide exchange factor activity(GO:0005085) |
0.0 | 0.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 22.0 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.7 | 5.4 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.6 | 0.6 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.6 | 22.5 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.6 | 11.2 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
0.6 | 12.9 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.5 | 20.6 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.5 | 1.9 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.5 | 23.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.4 | 2.7 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 2.7 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
0.4 | 2.9 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.4 | 2.1 | SIG BCR SIGNALING PATHWAY | Members of the BCR signaling pathway |
0.4 | 10.2 | PID ARF6 PATHWAY | Arf6 signaling events |
0.3 | 4.0 | PID CERAMIDE PATHWAY | Ceramide signaling pathway |
0.3 | 10.6 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 1.6 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.3 | 5.6 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.3 | 20.9 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.3 | 3.4 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.3 | 5.5 | PID AURORA A PATHWAY | Aurora A signaling |
0.3 | 8.1 | PID MAPK TRK PATHWAY | Trk receptor signaling mediated by the MAPK pathway |
0.3 | 9.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.3 | 7.2 | PID TNF PATHWAY | TNF receptor signaling pathway |
0.3 | 11.9 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.3 | 0.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.3 | 4.9 | PID RAS PATHWAY | Regulation of Ras family activation |
0.3 | 5.1 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.3 | 4.6 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 3.7 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
0.3 | 14.4 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.3 | 2.3 | PID MYC PATHWAY | C-MYC pathway |
0.3 | 9.7 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.3 | 23.4 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.3 | 3.7 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.2 | 1.3 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 2.6 | PID BCR 5PATHWAY | BCR signaling pathway |
0.2 | 5.9 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.2 | 4.9 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.2 | 0.8 | ST GAQ PATHWAY | G alpha q Pathway |
0.2 | 3.9 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.2 | 3.4 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.2 | 2.2 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.2 | 3.7 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.2 | 2.9 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.2 | 1.5 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.2 | 3.2 | PID P38 ALPHA BETA DOWNSTREAM PATHWAY | Signaling mediated by p38-alpha and p38-beta |
0.2 | 2.4 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.2 | 3.7 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.2 | 0.7 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.2 | 3.5 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.2 | 2.4 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
0.2 | 6.0 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.2 | 0.9 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.2 | 3.9 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.2 | 1.0 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.2 | 2.0 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
0.2 | 6.3 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.2 | 0.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.2 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.2 | 2.3 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.1 | 0.6 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
0.1 | 0.7 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 1.8 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 3.1 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.1 | 1.2 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.1 | 1.6 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 2.0 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.1 | 2.3 | ST FAS SIGNALING PATHWAY | Fas Signaling Pathway |
0.1 | 1.3 | PID ARF 3PATHWAY | Arf1 pathway |
0.1 | 2.8 | PID P53 REGULATION PATHWAY | p53 pathway |
0.1 | 0.3 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.1 | 1.2 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.1 | 2.0 | PID P73PATHWAY | p73 transcription factor network |
0.1 | 0.2 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 2.3 | PID ATR PATHWAY | ATR signaling pathway |
0.1 | 2.7 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.1 | 0.9 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 0.2 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.1 | 1.9 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 10.3 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.1 | 2.1 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.1 | 0.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.1 | 0.5 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.1 | 1.1 | PID AP1 PATHWAY | AP-1 transcription factor network |
0.1 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.1 | 0.5 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.1 | 1.5 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.1 | 0.5 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.1 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.1 | 1.3 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.1 | 0.8 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
0.1 | 1.1 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 0.7 | PID ERBB1 DOWNSTREAM PATHWAY | ErbB1 downstream signaling |
0.1 | 1.1 | PID LKB1 PATHWAY | LKB1 signaling events |
0.1 | 0.5 | PID BARD1 PATHWAY | BARD1 signaling events |
0.1 | 0.1 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
0.1 | 0.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.1 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.1 | 0.7 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
0.0 | 0.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.0 | 0.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.0 | 0.3 | PID ATM PATHWAY | ATM pathway |
0.0 | 0.7 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.4 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.0 | 0.0 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.0 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.0 | 0.8 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.7 | PID AURORA B PATHWAY | Aurora B signaling |
0.0 | 1.3 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.0 | 0.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.0 | 0.1 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.1 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.0 | 0.2 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.1 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.0 | 0.1 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.1 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.0 | 0.1 | PID SHP2 PATHWAY | SHP2 signaling |
0.0 | 0.5 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.0 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.2 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.0 | 0.0 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.0 | 0.1 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.0 | 4.3 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.1 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.0 | 0.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.0 | 0.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID ALK2 PATHWAY | ALK2 signaling events |
0.0 | 0.1 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.0 | 0.3 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 0.0 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.0 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.4 | 14.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
1.2 | 16.2 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
1.0 | 7.3 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.9 | 13.1 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
0.8 | 20.4 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.8 | 10.8 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.8 | 6.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.8 | 6.9 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
0.7 | 8.2 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.7 | 2.9 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.7 | 7.4 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.7 | 6.5 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
0.6 | 7.5 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.6 | 1.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.6 | 5.9 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.6 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.5 | 12.8 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.5 | 5.3 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.5 | 8.4 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 5.4 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.5 | 9.1 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.5 | 3.2 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.4 | 0.9 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.4 | 6.1 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.4 | 1.7 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.4 | 7.8 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.4 | 5.0 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.4 | 5.2 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.4 | 8.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.4 | 2.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.4 | 3.6 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.3 | 1.0 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.3 | 9.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.3 | 3.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 1.0 | REACTOME XENOBIOTICS | Genes involved in Xenobiotics |
0.3 | 0.6 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.3 | 1.9 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.3 | 1.0 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.3 | 5.1 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.3 | 8.3 | REACTOME PKB MEDIATED EVENTS | Genes involved in PKB-mediated events |
0.3 | 1.2 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.3 | 1.8 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 3.2 | REACTOME ASSOCIATION OF LICENSING FACTORS WITH THE PRE REPLICATIVE COMPLEX | Genes involved in Association of licensing factors with the pre-replicative complex |
0.3 | 3.2 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.3 | 2.3 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.3 | 3.4 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.3 | 3.0 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
0.3 | 2.2 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.3 | 3.3 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.3 | 2.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.3 | 8.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.3 | 3.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.3 | 12.2 | REACTOME AMINO ACID AND OLIGOPEPTIDE SLC TRANSPORTERS | Genes involved in Amino acid and oligopeptide SLC transporters |
0.3 | 2.3 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.3 | 1.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 5.5 | REACTOME KINESINS | Genes involved in Kinesins |
0.2 | 2.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 3.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.2 | 2.2 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.2 | 1.4 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 0.9 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.2 | 2.1 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.2 | 8.7 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.2 | 5.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.2 | 2.8 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.2 | 1.7 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.2 | 0.4 | REACTOME AUTODEGRADATION OF THE E3 UBIQUITIN LIGASE COP1 | Genes involved in Autodegradation of the E3 ubiquitin ligase COP1 |
0.2 | 0.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 0.8 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.2 | 1.0 | REACTOME TRAF3 DEPENDENT IRF ACTIVATION PATHWAY | Genes involved in TRAF3-dependent IRF activation pathway |
0.2 | 3.7 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.2 | 5.1 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.2 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.2 | 3.0 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.2 | 0.4 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.2 | 7.4 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.2 | 4.3 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
0.2 | 1.4 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 8.5 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.2 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.2 | 11.4 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 0.2 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.2 | 4.2 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.2 | 3.6 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.2 | 3.7 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.2 | 2.8 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.2 | 2.2 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.2 | 2.7 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.2 | 3.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.2 | 0.5 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 1.2 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 1.0 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.2 | 1.1 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.2 | 1.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
0.2 | 1.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.2 | 7.8 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
0.2 | 1.8 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.2 | 2.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.1 | 1.0 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.6 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.2 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 1.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 1.4 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.1 | 0.6 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.1 | 1.9 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.6 | REACTOME REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS | Genes involved in Regulation of mRNA Stability by Proteins that Bind AU-rich Elements |
0.1 | 3.9 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 0.5 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.1 | 7.7 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 2.9 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.1 | 1.3 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.1 | 16.5 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.1 | 2.9 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 3.2 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.1 | 0.2 | REACTOME CDC6 ASSOCIATION WITH THE ORC ORIGIN COMPLEX | Genes involved in CDC6 association with the ORC:origin complex |
0.1 | 1.2 | REACTOME N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE | Genes involved in N-glycan trimming in the ER and Calnexin/Calreticulin cycle |
0.1 | 0.9 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.1 | 0.1 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.1 | 2.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.1 | 3.3 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
0.1 | 1.0 | REACTOME SIGNALING BY THE B CELL RECEPTOR BCR | Genes involved in Signaling by the B Cell Receptor (BCR) |
0.1 | 1.0 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
0.1 | 0.7 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 9.4 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 0.7 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.4 | REACTOME ACYL CHAIN REMODELLING OF PG | Genes involved in Acyl chain remodelling of PG |
0.1 | 0.4 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 0.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 0.2 | REACTOME TRAF6 MEDIATED NFKB ACTIVATION | Genes involved in TRAF6 mediated NF-kB activation |
0.1 | 0.5 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 1.1 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.1 | 1.1 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.1 | 4.6 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.1 | 0.4 | REACTOME ROLE OF SECOND MESSENGERS IN NETRIN1 SIGNALING | Genes involved in Role of second messengers in netrin-1 signaling |
0.1 | 0.7 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.1 | 1.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.1 | 0.8 | REACTOME POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS | Genes involved in Post-translational modification: synthesis of GPI-anchored proteins |
0.1 | 1.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 0.1 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.1 | 0.5 | REACTOME MICRORNA MIRNA BIOGENESIS | Genes involved in MicroRNA (miRNA) Biogenesis |
0.1 | 0.3 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.1 | 0.6 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 3 Promoter |
0.1 | 0.6 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.1 | 3.5 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.4 | REACTOME MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES | Genes involved in MAPK targets/ Nuclear events mediated by MAP kinases |
0.1 | 0.3 | REACTOME ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS | Genes involved in Activation of ATR in response to replication stress |
0.1 | 1.1 | REACTOME CITRIC ACID CYCLE TCA CYCLE | Genes involved in Citric acid cycle (TCA cycle) |
0.1 | 1.0 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.1 | 0.4 | REACTOME REGULATION OF IFNA SIGNALING | Genes involved in Regulation of IFNA signaling |
0.1 | 1.5 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.1 | 0.9 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.1 | 0.4 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.1 | 8.6 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.1 | 0.8 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.4 | REACTOME FORMATION OF RNA POL II ELONGATION COMPLEX | Genes involved in Formation of RNA Pol II elongation complex |
0.1 | 1.5 | REACTOME REGULATION OF WATER BALANCE BY RENAL AQUAPORINS | Genes involved in Regulation of Water Balance by Renal Aquaporins |
0.1 | 0.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.1 | 5.5 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 1.2 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 0.6 | REACTOME HOST INTERACTIONS OF HIV FACTORS | Genes involved in Host Interactions of HIV factors |
0.1 | 0.8 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.1 | 0.6 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.1 | 0.6 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.8 | REACTOME INTERFERON SIGNALING | Genes involved in Interferon Signaling |
0.1 | 1.0 | REACTOME RNA POL II PRE TRANSCRIPTION EVENTS | Genes involved in RNA Polymerase II Pre-transcription Events |
0.1 | 1.5 | REACTOME APOPTOSIS | Genes involved in Apoptosis |
0.1 | 0.4 | REACTOME COPI MEDIATED TRANSPORT | Genes involved in COPI Mediated Transport |
0.1 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.1 | 0.7 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 0.5 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.1 | 0.9 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.1 | 1.3 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.1 | 0.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 1.1 | REACTOME SPHINGOLIPID METABOLISM | Genes involved in Sphingolipid metabolism |
0.1 | 0.3 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
0.1 | 1.8 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.1 | 1.5 | REACTOME TRANS GOLGI NETWORK VESICLE BUDDING | Genes involved in trans-Golgi Network Vesicle Budding |
0.1 | 0.3 | REACTOME SIGNALING BY NOTCH3 | Genes involved in Signaling by NOTCH3 |
0.1 | 1.0 | REACTOME CHONDROITIN SULFATE BIOSYNTHESIS | Genes involved in Chondroitin sulfate biosynthesis |
0.0 | 0.7 | REACTOME ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S | Genes involved in Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S |
0.0 | 1.6 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.0 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.4 | REACTOME FORMATION OF TUBULIN FOLDING INTERMEDIATES BY CCT TRIC | Genes involved in Formation of tubulin folding intermediates by CCT/TriC |
0.0 | 0.3 | REACTOME MITOTIC G2 G2 M PHASES | Genes involved in Mitotic G2-G2/M phases |
0.0 | 1.0 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.7 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME FGFR4 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR4 ligand binding and activation |
0.0 | 0.2 | REACTOME GAMMA CARBOXYLATION TRANSPORT AND AMINO TERMINAL CLEAVAGE OF PROTEINS | Genes involved in Gamma-carboxylation, transport, and amino-terminal cleavage of proteins |
0.0 | 0.5 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.0 | 0.2 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.0 | 0.0 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
0.0 | 1.5 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.0 | REACTOME BILE ACID AND BILE SALT METABOLISM | Genes involved in Bile acid and bile salt metabolism |
0.0 | 0.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.3 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
0.0 | 1.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 0.0 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.0 | 0.3 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.0 | 1.4 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 2.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.0 | 0.1 | REACTOME REGULATORY RNA PATHWAYS | Genes involved in Regulatory RNA pathways |
0.0 | 0.3 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.0 | 0.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.0 | 0.0 | REACTOME CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE | Genes involved in Cell death signalling via NRAGE, NRIF and NADE |
0.0 | 0.1 | REACTOME HOMOLOGOUS RECOMBINATION REPAIR OF REPLICATION INDEPENDENT DOUBLE STRAND BREAKS | Genes involved in Homologous recombination repair of replication-independent double-strand breaks |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.5 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.1 | REACTOME RNA POL II TRANSCRIPTION | Genes involved in RNA Polymerase II Transcription |
0.0 | 0.2 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
0.0 | 1.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.1 | REACTOME G PROTEIN ACTIVATION | Genes involved in G-protein activation |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 0.2 | REACTOME DNA REPLICATION | Genes involved in DNA Replication |
0.0 | 0.3 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.0 | 0.1 | REACTOME RIP MEDIATED NFKB ACTIVATION VIA DAI | Genes involved in RIP-mediated NFkB activation via DAI |
0.0 | 0.0 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.0 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.1 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.0 | 1.2 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |